United States, State of Illinois, State of Colorado, and State of Indiana, 31465-31477 [2010-13394]
Download as PDF
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of 6.50 (25 cents per page
reproduction cost) payable to the U.S.
Treasury or, if by e-mail or fax, forward
a check in that amount to the Consent
Decree Library at the stated address.
Maureen Katz,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2010–13278 Filed 6–2–10; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Antitrust Division
sroberts on DSKD5P82C1PROD with NOTICES
United States, State of Illinois, State of
Colorado, and State of Indiana v. AMC
Entertainment Holdings, Inc. and
Kerasotes Showplace Theatres, LLC
Proposed Final Judgment and
Competitive Impact Statement
Notice is hereby given pursuant to the
Antitrust Procedures and Penalties Act,
15 U.S.C. Section 16(b)–(h), that a
proposed Final Judgment, Stipulation
and Competitive Impact Statement have
been filed with the United States
District Court for the District of
Columbia in United States of America,
State of Illinois, State of Colorado, and
State of Indiana v. AMC Entertainment
Holdings, Inc. and Kerasotes Showplace
Theatres, LLC, Civil Action No. 1:10–
cv–00846. On May 21, 2010, the United
States and co-plaintiffs filed a
Complaint alleging that the proposed
acquisition of most of the assets of
Kerasotes Showplace Theatres, LLC by
AMC Entertainment Holdings, Inc.
would violate Section 7 of the Clayton
Act, 15 U.S.C. 18 by lessening
competition for theatrical exhibition of
first-run films in the Chicago, Denver
and Indianapolis metropolitan areas.
The proposed Final Judgment, filed at
the same time as the Complaint,
requires AMC Entertainment Holdings,
Inc. to divest first-run, commercial
movie theatres, along with certain
tangible and intangible assets, in those
three cities in order to proceed with the
proposed $275 million transaction.
Copies of the Complaint, proposed
Final Judgment and Competitive Impact
Statement are available for inspection at
the Department of Justice, Antitrust
Division, Antitrust Documents Group,
450 Fifth Street, NW., Suite 1010,
Washington, DC 20530 (telephone 202–
514–2481), on the Department of
Justice’s Web site at https://
www.usdoj.gov/atr, and at the Office of
the Clerk of the United States District
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
Court for the District of Columbia,
Washington, DC. Copies of these
materials may be obtained from the
Antitrust Division upon request and
payment of the copying fee set by
Department of Justice regulations.
Public comment is invited within 60
days of the date of this notice. Such
comments, and responses thereto, will
be published in the Federal Register
and filed with the Court. Comments
should be directed to John R. Read,
Chief, Litigation III Section, Antitrust
Division, United States Department of
Justice, 450 Fifth Street, NW., Suite
4000, Washington, DC 20530
(telephone: 202–307–0468).
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA
UNITED STATES OF AMERICA, U.S.
Department of Justice, Antitrust Division, 450
Fifth Street, NW., Suite 4000, Washington,
DC 20530, STATE OF ILLINOIS, Office of the
Attorney General, State of Illinois, 100 West
Randolph Street, 13th Floor, Chicago, Illinois
60601, STATE OF COLORADO, Office of the
Colorado Attorney General, 1525 Sherman
St., Seventh Floor, Denver, Colorado 80203,
and STATE OF INDIANA, Consumer
Protection Division, Office of the Indiana
Attorney General, Indiana Government
Center South, 302 W. Washington, 5th Floor,
Indianapolis, IN 46204, Plaintiffs, v. AMC
ENTERTAINMENT HOLDINGS, INC., 920
Main Street, Kansas City, Missouri 64105 and
KERASOTES SHOWPLACE THEATRES,
LLC, 224 North Des Plaines, Suite 200,
Chicago, Illinois 60661, Defendants.
Civil Action No: 1:10–cv–00846
Judge: Kennedy, Henry H.
Filed: 5/21/2010.
Complaint
The United States of America, acting
under the direction of the Attorney
General of the United States, and the
States of Illinois, Colorado, and Indiana,
acting through their Attorneys General,
bring this civil antitrust action to
prevent AMC Entertainment Holdings,
Inc. (‘‘AMC’’) from acquiring most of the
assets of Kerasotes Showplace Theatres,
LLC (‘‘Kerasotes’’). If the acquisition is
permitted, it would combine under
common ownership the two leading,
and in some cases only, mainstream
movie theatres showing first-run
commercial movies in certain parts of
the metropolitan areas of Chicago,
Denver, and Indianapolis. The
transaction would substantially lessen
competition and tend to create a
monopoly in mainstream theatres in
these markets in violation of Section 7
of the Clayton Act, 15 U.S.C. 18.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
31465
I. Jurisdiction and Venue
1. This action is filed by the United
States pursuant to Section 15 of the
Clayton Act, as amended, 15 U.S.C. 25,
to obtain equitable relief and to prevent
a violation of Section 7 of the Clayton
Act, as amended, 15 U.S.C. 18. The
States of Illinois, Colorado and Indiana
bring this action under Section 16 of the
Clayton Act, 15 U.S.C. 26, to prevent the
defendants from violating Section 7 of
the Clayton Act, as amended, 15 U.S.C.
18.
2. Defendants have consented to
personal jurisdiction in this District. In
addition, defendant AMC, through its
subsidiary, AMC Entertainment, Inc.,
operates theatres in this District. The
licensing and exhibition of first-run,
commercial films is a commercial
activity that substantially affects, and is
in the flow of, interstate trade and
commerce. Defendants’ activities in
purchasing equipment, services, and
supplies as well as licensing films for
their theatres substantially affect
interstate commerce. The Court has
jurisdiction over the subject matter of
this action and jurisdiction over the
parties pursuant to 15 U.S.C. 22, 25, and
26, and 28 U.S.C. 1331, 1337(a), and
1345.
3. Venue in this District is proper
under 15 U.S.C. 22 and 28 U.S.C.
1391(c).
II. Defendants and the Proposed
Transaction
4. Defendant AMC is a Delaware
corporation with its headquarters in
Kansas City, Missouri. It is the holding
company of AMC Entertainment, Inc.
AMC owns or operates 304 theatres
containing 4,574 screens in locations
throughout the United States and four
foreign countries. Measured by number
of screens, AMC is the second-largest
theatre circuit in the United States.
5. Defendant Kerasotes is a Delaware
corporation with its principal place of
business in Chicago, Illinois. It owns or
operates 96 theatres with 973 screens in
various states. Kerasotes is the sixthlargest theatre circuit in the United
States.
6. On January 19, 2010, AMC and
Kerasotes signed a purchase and sale
agreement, under which AMC acquired
Kerasotes (with the exception of three
theatres that will be retained by the
Kerasotes family) for approximately
$275 million.
III. Background of the Movie Industry
7. Theatrical exhibition of feature
length motion picture films (‘‘movies’’)
provides a major source of out-of-home
entertainment in the United States.
E:\FR\FM\03JNN1.SGM
03JNN1
31466
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
8. Viewing movies in the theatre is a
popular pastime. Over 1.4 billion movie
tickets were sold in the United States in
2009, with total box office revenue
exceeding $10.6 billion.
9. Companies that operate movie
theatres are called ‘‘exhibitors.’’ Some
exhibitors own a single theatre, whereas
others own a circuit of theatres within
one or more regions of the United
States. Established exhibitors include
Regal, Carmike, and Cinemark, as well
as AMC and Kerasotes.
10. Exhibitors set ticket prices for
each theatre based on a number of
factors, including the presence and
competitive decisions of nearby
comparable theatres.
IV. Relevant Markets
sroberts on DSKD5P82C1PROD with NOTICES
A. Product Market
11. Movies are a unique form of
entertainment. The experience of
viewing a movie in a theatre differs from
live entertainment (e.g., a stage
production), a sporting event, or
viewing a movie in the home (e.g., on
a DVD or via pay-per view).
12. Home viewing of movies is not a
reasonable substitute for viewing
movies in a theatre. When consumers
watch movies in their homes, they
typically lose several advantages of the
theatre experience, including the size of
screen, the sophistication of sound
systems, the opportunity to watch in
3–D, and the social experience of
viewing a movie with other patrons.
Additionally, the most popular, newly
released or ‘‘first-run’’ movies are not
available for home viewing.
13. Differences in the pricing of
various forms of entertainment also
reflect their lack of substitutability in
the eyes of consumers. Ticket prices for
movies are generally different from
prices for other forms of entertainment.
Tickets for most forms of live
entertainment are typically significantly
more expensive than movie tickets.
Renting a DVD for home viewing is
usually significantly less expensive than
viewing a movie in a theatre.
14. AMC and Kerasotes operate movie
theatres that exhibit first-run,
commercial movies (‘‘mainstream
theatres’’). Mainstream theatres typically
are multi-plex movie theatres that show
a wide variety of first-run, commercial
movies in order to attract all ages of
moviegoers, from children to seniors.
Mainstream theatres typically offer basic
concessions, such as popcorn, candy
and soft drinks.
15. Mainstream theatres do not
compete significantly with ‘‘sub-run’’
theatres specializing in exhibiting
movies after the four-to-five-week first
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
run has ended, with theatres
specializing in art movies or foreign
language movies, or with ‘‘premiere’’
theatres which typically offer fullservice dining, alcoholic beverages, an
adults-only environment, and other
luxury services and amenities not found
in mainstream theatres.
16. Tickets at mainstream theatres
usually cost significantly more than
tickets at sub-run theatres. Movies
exhibited at sub-run theatres are no
longer new releases, and moviegoers
generally do not regard sub-run movies
as adequate substitutes for first-run
movies.
17. Theatres that show art movies and
foreign language movies are also not
reasonable substitutes for mainstream
theatres. Commercial movies typically
appeal to different patrons than other
types of movies, such as art movies or
foreign language movies. For example,
art movies tend to appeal more
universally to mature audiences.
Theatres that primarily exhibit art
movies often contain auditoriums with
fewer seats than mainstream theatres.
Typically, art movies are released less
widely than commercial movies.
18. Premiere theaters do not typically
serve as a competitive constraint on
mainstream theaters. Premiere theatres
often show first-run, commercial
movies, but typically have more
restrictive admission policies (e.g.,
minors must be accompanied by adults
for all movies), charge higher ticket
prices (sometimes as much as double
the admission charged by typical firstrun theatres), serve alcoholic beverages,
and often offer full-service restaurants
or in-service dining. Premiere theatres
also differ from mainstream theatres in
the luxury items and amenities they
offer to their guests. For instance, in
addition to expanded food and beverage
offerings, premiere theatres often feature
reserved seating, leather and reclining
seats, wait service, and complimentary
refills of popcorn and sodas. Because of
these differences, premiere theatres
attract an audience that is distinct from
the audience for mainstream theatres.
19. The relevant product market
within which to assess the competitive
effects of this transaction is the
exhibition of first-run, commercial
movies in mainstream theatres.
B. Geographic Markets
20. Moviegoers typically are not
willing to travel very far from their
homes to attend a movie. As a result,
geographic markets for mainstream
theatres are relatively local.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Chicago, Illinois Area
21. AMC and Kerasotes account for a
substantial portion of the mainstream
theatre screens and ticket sales in three
areas of the Chicago metropolitan area—
the North Suburban Chicago area, the
Upper Southwest Suburban Chicago
area, and the Lower Southwest
Suburban Chicago area.
22. The North Suburban Chicago area,
in and around the communities of
Glenview and Skokie, encompasses
AMC’s Northbrook Court 14, Kerasotes’
Glen 10, AMC’s Gardens 13, Kerasotes’
Village Crossing 18, and Kerasotes’
Showplace 12 (Niles) theatres. There are
no other mainstream theatres in this
North Suburban Chicago area.
23. The Upper Southwest Suburban
Chicago area, in and around the city of
Naperville, encompasses AMC’s Cantera
30 and Kerasotes’ Showplace 16
(Naperville) theatres. There are no other
mainstream theatres in this Upper
Southwest Suburban Chicago area.
24. The Lower Southwest Suburban
Chicago area, in and around the village
of Bolingbrook, encompasses AMC’s
Woodridge 18 and Kerasotes’
Showplace 12 (Bolingbrook) theatres.
There is only one other non-party
mainstream theatre in this Lower
Southwest Suburban area—a 16-screen
Cinemark.
25. Moviegoers who reside in these
three suburban Chicago, Illinois areas
are reluctant to travel significant
distances out of each of these areas to
attend a movie except in unusual
circumstances. The relevant geographic
markets in which to assess the
competitive effects of this transaction
are the North Suburban Chicago, Upper
Southwest Suburban Chicago, and
Lower Southwest Suburban Chicago
areas.
Denver, Colorado Area
26. AMC and Kerasotes account for a
substantial portion of the mainstream
theatre screens and ticket sales in two
areas of the Denver metropolitan area.
27. The Upper Northwest Denver area,
in and around the cities of Louisville
and Broomfield, encompasses Kerasotes’
Colony Square 12 and AMC’s Flatiron
Crossing 14 theatres. There are no other
mainstream theatres in this Upper
Northwest Denver area.
28. The Lower Northwest Denver area,
in and around the cities of Westminster
and Arvada, encompasses AMC’s
Westminster Promenade 24 and
Kerasotes’ Olde Town 14 theatres. There
are no other mainstream theatres in this
Lower Northwest Denver area.
29. Moviegoers who reside in these
two Denver, Colorado areas are reluctant
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
to travel significant distances out of
each of these areas to attend a movie
except in unusual circumstances. The
relevant geographic markets in which to
assess the competitive effects of this
transaction are the Upper Northwest
Denver and Lower Northwest Denver
areas.
sroberts on DSKD5P82C1PROD with NOTICES
Indianapolis, Indiana Area
30. AMC and Kerasotes account for a
substantial portion of the first-run
movie screens and ticket sales in two
areas of the Indianapolis metropolitan
area.
31. The North Indianapolis area, in
and around the community of Glendale,
encompasses AMC’s Castleton Square
14 and Kerasotes’ Glendale Town 12
theatres. There is only one other nonparty mainstream theatre in this North
Indianapolis area—a Regal theatre with
14 screens.
32. The South Indianapolis area, in
and around the city of Greenwood,
encompasses AMC’s Greenwood 14 and
Kerasotes’ Showplace 16 and IMAX.
There are no other mainstream theatres
in this South Indianapolis area.
33. Moviegoers who reside in these
Indianapolis, Indiana areas are reluctant
to travel significant distances out of
each of these areas to attend a movie
except in unusual circumstances. The
relevant geographic market in which to
assess the competitive effects of this
transaction are the North Indianapolis
and the South Indianapolis areas.
C. The Relevant Markets
34. A small but significant postacquisition increase in movie ticket
prices at mainstream theatres in the
relevant geographic markets would not
cause a sufficient number of customers
to shift to other alternatives, including
to other forms of entertainment, to nonmainstream theatres, or to mainstream
theatres outside the relevant geographic
markets described above in sufficient
numbers to make such a price increase
unprofitable for the newly combined
entity. Therefore, the relevant markets
in which to assess the competitive
effects of this transaction are the
mainstream theatres in the North
Suburban Chicago, Upper Southwest
Suburban Chicago, Lower Southwest
Suburban Chicago, Upper Northwest
Denver, Lower Northwest Denver, North
Indianapolis, and South Indianapolis
areas.
V. Competitive Effects
35. Exhibitors compete on multiple
dimensions to attract moviegoers to
their theatres over the theatres of their
rivals. They compete over the quality of
the viewing experience. They compete
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
to offer the most sophisticated sound
and viewing systems, best picture
clarity, nicest seats with best views, and
cleanest floors and lobbies for
moviegoers. Exhibitors also compete on
price, knowing that if they charge too
much (or do not offer sufficient
discounted tickets for matinees, seniors,
children, etc.), moviegoers might visit
rival theatres.
36. In the geographic markets of the
North Suburban Chicago area, the Upper
Southwest Suburban Chicago area, the
Lower Southwest Suburban Chicago
area, the Upper Northwest Denver area,
the Lower Northwest Denver area, the
North Indianapolis area, and the South
Indianapolis area, AMC and Kerasotes
compete head-to-head for moviegoers.
These geographic markets are
concentrated, and in each market AMC
and Kerasotes are the other’s most
significant competitor, given their
proximity to one another and similarity
in size and quality of viewing
experience. Competition between AMC
and Kerasotes spurs each to improve its
quality and keeps prices in check.
Chicago, Illinois Area
37. In the North Suburban Chicago
area, the proposed transaction would
give the combined entity control of all
five mainstream theatres in that area,
with 83 out of 83 total screens and a
100% share of 2009 box office revenues,
which totaled approximately $24.9
million. Using a measure of market
concentration called the HerfindahlHirschman Index (‘‘HHI’’), explained in
Appendix A, the transaction would
yield a post-transaction HHI of
approximately 10,000, representing an
increase of 4,856.
38. In the Upper Southwest Suburban
Chicago area, the proposed transaction
would give the newly combined entity
control of the only two mainstream
theatres in that area, with 46 out of 46
total screens and a 100% share of 2009
box office revenues, which totaled
approximately $16.4 million. The
transaction would yield a posttransaction HHI of approximately
10,000, representing an increase of
4,875.
39. In the Lower Southwest Suburban
Chicago area, the proposed transaction
would give the newly combined entity
control of two of the three mainstream
theatres in that area, with 30 out of 46
total screens and a 53.0% share of 2009
box office revenues, which totaled
approximately $12.3 million. The
transaction would yield a posttransaction HHI of approximately 5,017,
representing an increase of 1,221.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
31467
Denver, Colorado Area
40. In the Upper Northwest Denver
area, the proposed transaction would
give the newly combined entity control
of the only two mainstream theatres in
that area, with 26 out of 26 total screens
and a 100% share of 2009 box office
revenues, which totaled approximately
$5.3 million. The transaction would
yield a post-transaction HHI of
approximately 10,000, representing an
increase of 4,356.
41. In the Lower Northwest Denver
area, the proposed transaction would
give the newly combined entity control
of the only two mainstream theatres in
that area, with 38 out of 38 total screens
and a 100% share of 2009 box office
revenues, which totaled approximately
$13.3 million. The transaction would
yield a post-transaction HHI of
approximately 10,000, representing an
increase of 3,669.
Indianapolis, Indiana Area
42. In the North Indianapolis area, the
proposed transaction would give the
newly combined entity control of two of
the three mainstream theatres in that
area, with 26 out of 40 total screens and
a 76.1% share of 2009 box office
revenues, which totaled approximately
$9.3 million. The transaction would
yield a post-transaction HHI of
approximately 6,357, representing an
increase of 2,689.
43. In the South Indianapolis area, the
proposed transaction would give the
newly combined entity control of the
only two mainstream theatres in that
area, with 30 out of 30 total screens and
a 100% share of 2009 box office
revenues, which totaled approximately
$10.1 million. The transaction would
yield a post-transaction HHI of
approximately 10,000, representing an
increase of 4,838.
44. The proposed transaction would
likely lessen competition significantly
in the relevant markets. Today, if AMC
or Kerasotes were to increase its prices
at a theatre in one of the relevant
markets, and the other did not follow,
the theatre that increased its prices
might lose business to the other. The
proposed transaction would eliminate
this pricing constraint and is therefore
likely to lead to higher prices for
moviegoers, which could take the form
of a higher adult evening ticket price or
reduced discounting, e.g., for matinees,
children, seniors, and students.
45. The proposed transaction would
also eliminate competition between
AMC and Kerasotes over the quality of
the viewing experience in each of the
geographic markets at issue. The
combined entity would have reduced
E:\FR\FM\03JNN1.SGM
03JNN1
31468
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
incentives to maintain, upgrade, and
renovate its theatres in the relevant
markets, and to improve those theatres’
amenities and services, thus reducing
the quality of the viewing experience for
a moviegoer.
46. The presence in some of the
relevant geographic markets of other
non-party mainstream theatres would be
insufficient to replace the competition
lost due to the transaction and thus
render unprofitable post-transaction
increases in ticket prices or decreases in
quality by the newly combined entity.
VI. Entry
47. Sufficient and timely entry that
would deter or counteract the
anticompetitive effects alleged above is
unlikely. Exhibitors are reluctant to
locate new mainstream theatres near
existing theatres unless the population
density, demographics, or the quality of
existing theatres makes new entry
viable. Those conditions do not exist in
any of the relevant geographic markets.
VII. Violation Alleged
48. The plaintiffs hereby
reincorporate paragraphs 1 through 47.
49. The effect of the proposed
transaction would be to lessen
competition substantially in the relevant
geographic markets in violation of
Section 7 of the Clayton Act, 15 U.S.C.
18.
50. The transaction would likely have
the following effects, among others: (a)
Prices for first-run, commercial movie
tickets in mainstream theatres would
likely increase to levels above those that
would prevail absent the transaction;
and (b) the quality of mainstream
theatres and the mainstream theatre
viewing experience in the relevant
geographic areas would likely decrease
below levels that would prevail absent
the transaction.
sroberts on DSKD5P82C1PROD with NOTICES
VIII. Requested Relief
51. The plaintiffs request: (a)
Adjudication that the proposed
transaction would violate Section 7 of
the Clayton Act; (b) permanent
injunctive relief to prevent the
consummation of the proposed
transaction; (c) an award to each
plaintiff of its costs in this action; and
(d) such other relief as is proper.
William F. Cavanaugh, Jr.,
Deputy Assistant Attorney General
/s/ lllllllllllllllllll
Patricia A. Brink,
Deputy Director of Operations
/s/ lllllllllllllllllll
John R. Read,
Chief
David Kully,
Assistant Chief
Litigation III
/s/ lllllllllllllllllll
Gregg I. Malawer, (DC Bar No. 481685)
Nina B. Hale
Bennett J. Matelson, (DC Bar No. 454551)
Creighton J. Macy,
U.S. Department of Justice, Antitrust
Division, 450 5th Street, NW., Suite 4000,
Washington, DC 20530, Telephone: (202)
616–5943, Fax: (202) 514–7308, E-mail:
gregg.malawer@usdoj.gov, Attorneys for
Plaintiff the United States
Dated: May 21, 2010.
For Plaintiff State of Illinois:
Lisa Madigan,
Attorney General
/s/ lllllllllllllllllll
By: Robert Pratt, Chief, Antitrust Bureau,
Office of the Attorney General, State of
Illinois, 100 West Randolph Street, 13th
Floor, Chicago, Illinois 60601, Telephone:
(312) 814–3722, Fax: (312) 814–4209, E-mail:
RPratt@atg.state.il.us
For Plaintiff State of Colorado:
John Suthers,
Attorney General
/s/ lllllllllllllllllll
By: Devin Laiho, Assistant Attorney General,
Antitrust Enforcement, Office of the Colorado
Attorney General, 1525 Sherman St., Seventh
Floor, Denver, Colorado 80203, Telephone:
(303) 866–5079, Fax: (303) 866–5691, E-mail:
Devin.Laiho@state.co.us
For Plaintiff State of Indiana:
Greg Zoeller,
Attorney General
/s/ lllllllllllllllllll
By: Abigail Lawlis Kuzma, Director and Chief
Counsel, Consumer Protection Division,
Office of the Indiana Attorney General,
Indiana Government Center South, 302 W.
Washington, 5th Floor, Indianapolis, IN
46204, Telephone: (317) 234–6843, Fax: (317)
232–7979, E-mail: AKuzuma@atg.in.gov
Appendix A
Definition of HHI and Calculations for
Market
‘‘HHI’’ means the Herfindahl-Hirschman
Index, a commonly accepted measure of
market concentration. It is calculated by
squaring the market share of each firm
competing in the market and then summing
Dated: May 21, 2010.
the resulting numbers. For example, for a
For Plaintiff United States of America
market consisting of four firms with shares of
/s/ lllllllllllllllllll thirty, thirty, twenty and twenty percent, the
Christine A. Varney,
HHI is 2,600 (302 + 302 + 202 + 202 = 2,600).
Assistant Attorney General, Antitrust
The HHI takes into account the relative size
Division
and distribution of the firms in a market and
/s/ lllllllllllllllllll approaches zero when a market consists of a
Molly S. Boast,
large number of firms of relatively equal size.
Deputy Assistant Attorney General
The HHI increases both as the number of
/s/ lllllllllllllllllll firms in the market decreases and as the
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
disparity in size between those firms
increases.
Markets in which the HHI is between 1,000
and 1,800 points are considered to be
moderately concentrated, and those in which
the HHI is in excess of 1,800 points are
considered to be concentrated. Transactions
that increase the HHI by more than 100
points in concentrated markets
presumptively raise antitrust concerns under
the Merger Guidelines. See Merger
Guidelines 1.51.
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA
UNITED STATES OF AMERICA, STATE
OF ILLINOIS, STATE OF COLORADO and
STATE OF INDIANA, Plaintiffs, v. AMC
ENTERTAINMENT HOLDINGS, INC., and
KERASOTES SHOWPLACE THEATRES,
LLC, Defendants.
Civil Action No: 10–0846
Judge:
Filed: 5/21/2010.
Final Judgment
Whereas, Plaintiffs, United States of
America, State of Illinois, State of
Colorado, and State of Indiana, filed
their Complaint on May 21, 2010, the
Plaintiffs and Defendants, AMC
Entertainment Holdings, Inc. (‘‘AMC’’)
and Kerasotes Showplace Theatres, LLC
(‘‘Kerasotes’’), by their respective
attorneys, have consented to the entry of
this Final Judgment without trial or
adjudication of any issue of fact or law,
and without this Final Judgment
constituting any evidence against or
admission by any party regarding any
issue of fact or law;
And Whereas, Defendants agree to be
bound by the provisions of this Final
Judgment pending its approval by the
Court;
And Whereas, the essence of this
Final Judgment is the prompt and
certain divestiture of certain rights or
assets by the Defendants to assure that
competition is not substantially
lessened;
And Whereas, Plaintiffs require
Defendants to make certain divestitures
for the purpose of remedying the loss of
competition alleged in the Complaint;
And Whereas, Defendants have
represented to the Plaintiffs that the
divestitures required below can and will
be made and that Defendants will later
raise no claim of hardship or difficulty
as grounds for asking the Court to
modify any of the divestiture provisions
contained below;
Now Therefore, before any testimony
is taken, without trial or adjudication of
any issue of fact or law, and upon
consent of the parties, it is ordered,
adjudged and decreed:
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
I. Jurisdiction
This Court has jurisdiction over the
subject matter of and each of the parties
to this action. The Complaint states a
claim upon which relief may be granted
against Defendants under Section 7 of
the Clayton Act, as amended (15 U.S.C.
18).
II. Definitions
As used in this Final Judgment:
A. ‘‘Acquirer’’ or ‘‘Acquirers’’ means
the entity or entities to which AMC
divests the Divestiture Assets.
B. ‘‘AMC’’ means defendant AMC
Entertainment Holdings, Inc., a
Delaware corporation with its principal
place of business in Kansas City,
Missouri, its successors and assigns, and
its subsidiaries, divisions, groups,
affiliates, partnerships and joint
ventures, and their directors, officers,
managers, agents, and employees.
C. ‘‘Kerasotes’’ means defendant
Kerasotes Showplace Theatres, LLC, a
Delaware corporation with its principal
place of business in Chicago, Illinois, its
successors and assigns, and its
subsidiaries, divisions, groups,
affiliates, partnerships and joint
ventures, and their directors, officers,
managers, agents, and employees.
D. ‘‘Landlord Consent’’ means any
contractual approval or consent that the
landlord or owner of one or more of the
Divestiture Assets, or of the property on
which one or more of the Divestiture
Assets is situated, must grant prior to
the transfer of one of the Divestiture
Assets to an Acquirer.
E. ‘‘Divestiture Assets’’ means the
following theatre assets:
Theatre
1
2
3
4
5
6
7
...........
...........
...........
...........
...........
...........
...........
sroberts on DSKD5P82C1PROD with NOTICES
8 ...........
Address
AMC Cantera 30 .............................................................................
Kerasotes Showplace 12 (Bolingbrook) ..........................................
Kerasotes Glen 10 ..........................................................................
AMC Gardens 13 ............................................................................
Kerasotes Colony Square 12 ..........................................................
Kerasotes Olde Town 14 ................................................................
Kerasotes Showplace 12 (Glendale 10) OR AMC Castleton
Square 14.
AMC Greenwood 14 ........................................................................
The term ‘‘Divestiture Assets’’
includes:
1. All tangible assets that comprise
the business of operating mainstream
theatres that exhibit first-run,
commercial movies, including, but not
limited to, real property and
improvements, research and
development activities, all equipment,
fixed assets, and fixtures, personal
property, inventory, office furniture,
materials, supplies, and other tangible
property and all assets used in
connection with the Divestiture Assets;
all licenses, permits, and authorizations
issued by any governmental
organization relating to the Divestiture
Assets; all contracts (including
management contracts), teaming
arrangements, agreements, leases,
commitments, certifications, and
understandings relating to the
Divestiture Assets, including supply
agreements; all customer lists (including
loyalty club data at the option of the
Acquirer(s), copies of which may be
retained by AMC at its option),
contracts, accounts, and credit records;
all repair and performance records and
all other records relating to the
Divestiture Assets;
2. All intangible assets used in the
development, production, servicing, and
sale of the Divestiture Assets, including,
but not limited to, all patents, licenses
and sublicenses, intellectual property,
copyrights, trademarks, trade names,
service marks, service names, technical
information, computer software (except
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
31469
28250 Diehl Road, Warrenville, IL 60555.
1221 West Boughton Road, Bolingbrook, IL 60440.
1850 Tower Drive, Glenview, IL 60026.
4999 Old Orchard Shopping Center, Skokie, IL 60077,
1164 West Dillon Road, Louisville, CO 80027.
5550 Wadsworth Boulevard, Arvada, CO 80002.
6102 N. Rural Street, Indianapolis, IN 46220.
6020 East 82nd Street, Indianapolis, IN 46250.
461 South Greenwood Park Drive, Greenwood, IN 46142.
Defendants’ proprietary software) and
related documentation, know-how,
trade secrets, drawings, blueprints,
designs, design protocols, specifications
for materials, specifications for parts
and devices, safety procedures for the
handling of materials and substances,
all research data concerning historic and
current research and development
relating to Divestiture Assets, quality
assurance and control procedures,
design tools and simulation capability,
all manuals and technical information
Defendants provide to their own
employees, customers, suppliers, agents,
or licensees, and all research data
concerning historic and current research
and development efforts relating to the
Divestiture Assets; provided, however,
that this term does not include assets
that the Defendants do not own or that
AMC is not legally able to transfer.
III. Applicability
A. This Final Judgment applies to
AMC and Kerasotes, as defined above,
and all other persons in active concert
or participation with any of them who
receive actual notice of this Final
Judgment by personal service or
otherwise.
B. If, prior to complying with Sections
IV and V of this Final Judgment,
Defendants sell or otherwise dispose of
all or substantially all of their assets or
of lesser business units that include the
Divestiture Assets, they shall require the
purchaser to be bound by the provisions
of this Final Judgment. Defendants need
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
not obtain such an agreement from the
acquirers of the assets divested pursuant
to this Final Judgment.
IV. Divestitures
A. AMC is ordered and directed,
within sixty (60) calendar days after the
filing of the Complaint in this matter, or
five (5) calendar days after notice of the
entry of this Final Judgment by the
Court, whichever is later, to divest the
Divestiture Assets in a manner
consistent with this Final Judgment to
one or more Acquirer(s) acceptable to
the United States in its sole discretion
(after consultation with the State of
Illinois, the State of Colorado, and the
State of Indiana, as appropriate). The
United States, in its sole discretion, may
agree to one or more extensions of this
time period, and shall notify the Court
in such circumstances. AMC agrees to
use its best efforts to divest the
Divestiture Assets as expeditiously as
possible.
B. In accomplishing the divestitures
ordered by this Final Judgment, AMC
promptly shall make known, by usual
and customary means, the availability of
the Divestiture Assets. AMC shall
inform any person making inquiry
regarding a possible purchase of the
Divestiture Assets that they are being
divested pursuant to this Final
Judgment and provide that person with
a copy of this Final Judgment. AMC
shall offer to furnish to all prospective
Acquirers, subject to customary
confidentiality assurances, all
E:\FR\FM\03JNN1.SGM
03JNN1
sroberts on DSKD5P82C1PROD with NOTICES
31470
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
information and documents relating to
the Divestiture Assets customarily
provided in a due diligence process
except such information or documents
subject to the attorney-client privilege or
work-product doctrine. AMC shall make
available such information to the
Plaintiffs at the same time that such
information is made available to any
other person.
C. AMC shall provide the Acquirer(s)
and the United States information
relating to the personnel involved in the
operation of the Divestiture Assets to
enable the Acquirer(s) to make offers of
employment. Defendants will not
interfere with any negotiations by the
Acquirer(s) to employ any Defendant
employee whose primary responsibility
is the operation of the Divestiture
Assets.
D. AMC shall permit prospective
Acquirer(s) of the Divestiture Assets to
have reasonable access to personnel and
to make inspections of the physical
facilities of the Divestiture Assets;
access to any and all environmental,
zoning, and other permit documents
and information; and access to any and
all financial, operational, or other
documents and information customarily
provided as part of a due diligence
process.
E. AMC shall warrant to Acquirer(s) of
the Divestiture Assets that each asset
will be operational on the date of sale.
F. Defendants shall not take any
action that will impede in any way the
permitting, operation, or divestitures of
the Divestiture Assets. At the option of
the Acquirer(s), AMC shall enter into an
agreement for products and services,
such as computer support services, that
are reasonably necessary for the
Acquirer(s) to effectively operate the
Divestiture Assets during a transition
period. The terms and conditions of any
contractual arrangements meant to
satisfy this provision must be
commercially reasonable for those
products and services for which the
agreement is entered and shall remain
in effect for no more than three months,
absent approval of the United States, in
its sole discretion (after consultation
with the State of Illinois, the State of
Colorado, and the State of Indiana, as
appropriate).
G. AMC shall warrant to the
Acquirer(s) that there are no material
defects in the environmental, zoning, or
other permits pertaining to the
operation of each asset. Following the
sale of the Divestiture Assets,
Defendants will not undertake, directly
or indirectly, any challenges to the
environmental, zoning, or other permits
relating to the operation of the
Divestiture Assets.
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
H. Unless the United States (after
consultation with the State of Illinois,
the State of Colorado, and the State of
Indiana, as appropriate) otherwise
consents in writing, the divestitures
made pursuant to Section IV, or by
trustee appointed pursuant to Section V
of this Final Judgment, shall include the
entire Divestiture Assets, and shall be
accomplished in such a way as to satisfy
the United States, in its sole discretion
(after consultation with the State of
Illinois, the State of Colorado, and the
State of Indiana, as appropriate) that the
Divestiture Assets can and will be used
by the Acquirer(s) as part of a viable,
ongoing business of operating
mainstream theatres that exhibit firstrun, commercial movies. Divestitures of
the Divestiture Assets may be made to
one or more Acquirers, provided that in
each instance it is demonstrated to the
sole satisfaction of the United States
(after consultation with the State of
Illinois, the State of Colorado, and the
State of Indiana, as appropriate) that the
Divestiture Assets will remain viable
and the divestitures of such assets will
remedy the competitive harm alleged in
the Complaint. The divestitures,
whether pursuant to Section IV or
Section V of this Final Judgment.
(1) Shall be made to Acquirers that, in
the United States’ sole judgment (after
consultation with the State of Illinois,
the State of Colorado, and the State of
Indiana, as appropriate) have the intent
and capability (including the necessary
managerial, operational, technical, and
financial capability) of competing
effectively in the business of
mainstream theatres exhibiting first-run,
commercial movies; and
(2) Shall be accomplished so as to
satisfy the United States, in its sole
discretion (after consultation with the
State of Illinois, the State of Colorado,
and the State of Indiana, as appropriate)
that none of the terms of any agreement
between Acquirers and Defendants give
the ability unreasonably to raise the
Acquirers’ costs, to lower the Acquirers’
efficiency, or otherwise to interfere in
the ability of the Acquirers to compete
effectively.
V. Appointment of Trustee
A. If AMC has not divested the
Divestiture Assets within the time
period specified in Section IV(A), AMC
shall notify the United States of that fact
in writing. Upon application of the
United States, the Court shall appoint a
trustee selected by the United States and
approved by the Court to effect the
divestitures of the Divestiture Assets.
B. After the appointment of a trustee
becomes effective, only the trustee shall
have the right to sell the Divestiture
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Assets. The trustee shall have the power
and authority to accomplish the
divestitures to Acquirer(s) acceptable to
the United States (after consultation
with the State of Illinois, the State of
Colorado, and the State of Indiana, as
appropriate) at such price and on such
terms as are then obtainable upon
reasonable effort by the trustee, subject
to the provisions of Sections IV, V, VI,
and VII of this Final Judgment, and shall
have such other powers as this Court
deems appropriate. Subject to Section
V(D) of this Final Judgment, the trustee
may hire at the cost and expense of
AMC any investment bankers, attorneys,
or other agents, who shall be solely
accountable to the trustee, reasonably
necessary in the trustee’s judgment to
assist in the divestiture.
C. Defendants shall not object to a sale
by the trustee on any ground other than
the trustee’s malfeasance. Any such
objections by Defendants must be
conveyed in writing to the United States
and the trustee within ten (10) calendar
days after the trustee has provided the
notice required under Section VII.
D. The trustee shall serve at the cost
and expense of AMC, on such terms and
conditions as the United States
approves, and shall account for all
monies derived from the sale of the
assets sold by the trustee and all costs
and expenses so incurred. After
approval by the Court of the trustee’s
accounting, including fees for its
services and those of any professionals
and agents retained by the trustee, all
remaining money shall be paid to AMC
and the trust shall then be terminated.
The compensation of the trustee and
any professionals and agents retained by
the trustee shall be reasonable in light
of the value of the Divestiture Assets
and based on a fee arrangement
providing the trustee with an incentive
based on the price and terms of the
divestitures and the speed with which
it is accomplished, but timeliness is
paramount.
E. Defendants shall use their best
efforts to assist the trustee in
accomplishing the required divestitures.
The trustee and any consultants,
accountants, attorneys, and other
persons retained by the trustee shall
have full and complete access to the
personnel, books, records, and facilities
of the business to be divested, and
Defendants shall develop financial and
other information relevant to such
business as the trustee may reasonably
request, subject to reasonable protection
for trade secret or other confidential
research, development, or commercial
information. Defendants shall take no
action to interfere with or to impede the
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
trustee’s accomplishment of the
divestitures.
F. After its appointment, the trustee
shall file monthly reports with the
parties and the Court setting forth the
trustee’s efforts to accomplish the
divestitures ordered under this Final
Judgment. To the extent such reports
contain information that the trustee
deems confidential, such reports shall
not be filed in the public docket of the
Court. Such reports shall include the
name, address, and telephone number of
each person who, during the preceding
month, made an offer to acquire,
expressed an interest in acquiring,
entered into negotiations to acquire, or
was contacted or made an inquiry about
acquiring, any interest in the Divestiture
Assets, and shall describe in detail each
contact with any such person. The
trustee shall maintain full records of all
efforts made to divest the Divestiture
Assets.
G. If the trustee has not accomplished
the divestitures ordered under this Final
Judgment within six (6) months after its
appointment, the trustee shall promptly
file with the Court a report setting forth
(1) the trustee’s efforts to accomplish the
required divestitures, (2) the reasons, in
the trustee’s judgment, why the required
divestitures have not been
accomplished, and (3) the trustee’s
recommendations. To the extent such
reports contain information that the
trustee deems confidential, such reports
shall not be filed in the public docket
of the Court. The trustee shall at the
same time furnish such report to the
United States, which shall have the
right to make additional
recommendations consistent with the
purpose of the trust. The Court
thereafter shall enter such orders as it
shall deem appropriate to carry out the
purpose of the Final Judgment, which
may, if necessary, include extending the
trust and the term of the trustee’s
appointment by a period requested by
the United States.
sroberts on DSKD5P82C1PROD with NOTICES
VI. Landlord Consent
A. If AMC is unable to effect the
divestitures required herein due to the
inability to obtain the Landlord Consent
for any of the Divestiture Assets, AMC
shall divest alternative theatre assets
that compete effectively with the
theatres for which the Landlord Consent
was not obtained. The United States
shall, in its sole discretion (after
consultation with the State of Illinois,
the State of Colorado, and the State of
Indiana, as appropriate) determine
whether such theatre assets compete
effectively with the theatres for which
landlord consent was not obtained.
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
B. Within five (5) business days
following a determination that Landlord
Consent cannot be obtained for the
Divestiture Assets, AMC shall notify the
United States and propose an alternative
divestiture pursuant to Section VI(A).
The United States shall have then ten
(10) business days in which to
determine whether such theatre assets
are a suitable alternative pursuant to
Section VI(A). If AMC’s selection is
deemed not to be a suitable alternative,
the United States shall in its sole
discretion select the theatre assets to be
divested (after consultation with the
State of Illinois, the State of Colorado,
and the State of Indiana, as appropriate).
C. If the trustee is responsible for
effecting the divestitures, it shall notify
both the United States and AMC within
five (5) business days following a
determination that Landlord Consent
cannot be obtained for the Divestiture
Assets. AMC shall thereafter have five
(5) business days to propose an
alternative divestiture pursuant to
Section VI(A). The United States shall
have then ten (10) business days in
which to determine whether such
theatre assets are suitable alternative
pursuant to Section VI(A). If AMC’s
selection is deemed not to be a suitable
competitive alternative, the United
States shall in its sole discretion select
the theatre assets to be divested (after
consultation with the State of Illinois,
the State of Colorado, and the State of
Indiana, as appropriate).
VII. Notice of Proposed Divestitures
A. Within two (2) business days
following execution of a definitive
divestiture agreement, AMC or the
trustee, whichever is then responsible
for effecting the divestitures required
herein, shall notify the United States
(and, as appropriate, the State of
Illinois, the State of Colorado, and the
State of Indiana), of any proposed
divestitures required by Sections IV or
V of this Final Judgment. If the trustee
is responsible, it shall similarly notify
Defendants. The notice shall set forth
the details of the proposed divestitures
and list the name, address, and
telephone number of each person not
previously identified who offered or
expressed an interest in or desire to
acquire any ownership interest in the
Divestiture Assets, together with full
details of the same.
B. Within fifteen (15) calendar days of
receipt by the United States (the State of
Illinois, the State of Colorado, and the
State of Indiana) of such notice, the
United States may request from
Defendants, the proposed Acquirer(s),
any other third party, or the trustee, if
applicable, additional information
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
31471
concerning the proposed divestitures,
the proposed Acquirer(s), and any other
potential Acquirer(s). Defendants and
the trustee shall furnish any additional
information requested within fifteen
(15) calendar days of the receipt of the
request, unless the parties shall
otherwise agree.
C. Within thirty (30) calendar days
after receipt of the notice or within
twenty (20) calendar days after the
United States has been provided the
additional information requested from
Defendants, the proposed Acquirer(s),
any third party, and the trustee,
whichever is later, the United States
shall provide written notice to
Defendants and the trustee, if there is
one, stating whether or not it objects to
the proposed divestitures. If the United
States provides written notice that it
does not object, the divestitures may be
consummated, subject only to
Defendants’ limited right to object to the
sale under Section V(C) of this Final
Judgment. Absent written notice that the
United States does not object to the
proposed Acquirer(s) or upon objection
by the United States, a divestiture
proposed under Section IV or Section V
shall not be consummated. Upon
objection by Defendants under Section
V(C), a divestiture proposed under
Section V shall not be consummated
unless approved by the Court.
VIII. Financing
Defendants shall not finance all or
any part of any purchase made pursuant
to Section IV or V of this Final
Judgment.
IX. Hold Separate
Until the divestitures required by this
Final Judgment have been
accomplished, Defendants shall take all
steps necessary to comply with the Hold
Separate Stipulation and Order entered
by this Court. Defendants shall take no
action that would jeopardize the
divestitures ordered by this Court.
X. Affidavits
A. Within twenty (20) calendar days
of the filing of the Complaint in this
matter, and every thirty (30) calendar
days thereafter until the divestitures
have been completed under Sections IV
or V, AMC shall deliver to the United
States an affidavit as to the fact and
manner of its compliance with Sections
IV or V of this Final Judgment. Each
such affidavit shall include the name,
address, and telephone number of each
person who, during the preceding thirty
(30) calendar days, made an offer to
acquire, expressed an interest in
acquiring, entered into negotiations to
acquire, or was contacted or made an
E:\FR\FM\03JNN1.SGM
03JNN1
31472
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
inquiry about acquiring, any interest in
the Divestiture Assets, and shall
describe in detail each contact with any
such person during that period. Each
such affidavit shall also include a
description of the efforts AMC has taken
to solicit buyers for the Divestiture
Assets, and to provide required
information to prospective purchasers,
including the limitations, if any, on
such information. Assuming the
information set forth in the affidavit is
true and complete, any objection by the
United States to information provided
by AMC, including limitation on
information, shall be made within
fourteen (14) calendar days of receipt of
such affidavit.
B. Within twenty (20) calendar days
of the filing of the Complaint in this
matter, AMC shall deliver to the United
States an affidavit that describes in
reasonable detail all actions Defendants
have taken and all steps Defendants
have implemented on an ongoing basis
to comply with Section IX of this Final
Judgment. AMC shall deliver to the
United States an affidavit describing any
changes to the efforts and actions
outlined in AMC’s earlier affidavits filed
pursuant to this section within fifteen
(15) calendar days after the change is
implemented.
C. Defendants shall keep all records of
all efforts made to preserve and divest
the Divestiture Assets until one year
after such divestitures have been
completed.
XI. Compliance Inspection
A. For the purposes of determining or
securing compliance with this Final
Judgment, or of determining whether
the Final Judgment should be modified
or vacated, and subject to any legally
recognized privilege, from time to time
duly authorized representatives of the
United States Department of Justice
Antitrust Division (‘‘DOJ’’), including
consultants and other persons retained
by the United States, shall, upon written
request of an authorized representative
of the Assistant Attorney General in
charge of the Antitrust Division, and on
reasonable notice to Defendants, be
permitted:
(1) Access during Defendants’ office
hours to inspect and copy, or at
plaintiffs’ option, to require Defendants
to provide hard copy or electronic
copies of, all books, ledgers, accounts,
records, data, and documents in the
possession, custody, or control of
Defendants, relating to any matters
contained in this Final Judgment; and
(2) To interview, either informally or
on the record, Defendants’ officers,
employees, or agents, who may have
their individual counsel present,
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
regarding such matters. The interviews
shall be subject to the reasonable
convenience of the interviewee and
without restraint or interference by
Defendants.
B. Upon the written request of an
authorized representative of the
Assistant Attorney General in charge of
the Antitrust Division, Defendants shall
submit written reports or response to
written interrogatories, under oath if
requested, relating to any of the matters
contained in this Final Judgment as may
be requested.
C. No information or documents
obtained by the means provided in this
section shall be divulged by the United
States to any person other than an
authorized representative of the
executive branch of the United States,
except in the course of legal proceedings
to which the United States is a party
(including grand jury proceedings), or
for the purpose of securing compliance
with this Final Judgment, or as
otherwise required by law.
D. If at the time information or
documents are furnished by Defendants
to the United States, Defendants
represent and identify in writing the
material in any such information or
documents to which a claim of
protection may be asserted under Rule
26(c)(1)(G) of the Federal Rules of Civil
Procedure, and Defendants mark each
pertinent page of such material, ‘‘Subject
to claim of protection under Rule
26(c)(1)(G) of the Federal Rules of Civil
Procedure,’’ then the plaintiffs shall give
Defendants ten (10) calendar days notice
prior to divulging such material in any
legal proceeding (other than a grand jury
proceeding).
XII. Notification
Unless such transaction is otherwise
subject to the reporting and waiting
period requirements of the Hart-ScottRodino Antitrust Improvements Act of
1976, as amended, 15 U.S.C. 18a (the
‘‘HSR Act’’), AMC, without providing
advance notification to the DOJ, shall
not directly or indirectly acquire any
assets of or any interest, including any
financial, security, loan, equity or
management interest, in the business of
theatres exhibiting first-run, commercial
movies in Cook County, Illinois; Dupage
County, Illinois; Adams County,
Colorado; Boulder County, Colorado;
Jefferson County, Colorado; Marion
County, Indiana; and Johnson County,
Indiana during a ten year period.
Unless such transaction is otherwise
subject to the reporting and waiting
period requirements of the Hart-ScottRodino Antitrust Improvements Act of
1976, as amended, 15 U.S.C. 18a (the
‘‘HSR Act’’), Kerasotes, without
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
providing advance notification to the
DOJ, shall not directly or indirectly
acquire any assets of or any interest,
including any financial, security, loan,
or equity interest, in the business of
theatres exhibiting first-run, commercial
movies in Cook County, Illinois during
a ten year period. Notwithstanding the
preceding sentence, in no event shall
Kerasotes be required to provide
advance notification under this
provision of any of the following
activities: (i) engaging in a sale/
leaseback, developer-financed or similar
transaction, or developing internally
using its own or third-party financing,
in each case with respect to a newly
developed theatre; or (ii) making an
acquisition of not more than two
percent of the outstanding voting
securities of a publicly-traded company
with theatres exhibiting first-run,
commercial movies where such
investment is made ‘‘solely for the
purpose of investment’’ as that term is
construed under 15 U.S.C. 802.9.
Such notification shall be provided to
the DOJ in the same format as, and per
the instructions relating to the
Notification and Report Form set forth
in the Appendix to Part 803 of Title 16
of the Code of Federal Regulations as
amended, except that the information
requested in Items 5 through 9 of the
instructions must be provided only
about mainstream theatres that exhibit
first-run, commercial movies.
Notification shall be provided at least
thirty (30) calendar days prior to
acquiring any such interest, and shall
include, beyond what may be required
by the applicable instructions, the
names of the principal representatives
of the parties to the agreement who
negotiated the agreement, and any
management or strategic plans
discussing the proposed transaction. If
within the 30-day period after
notification, representatives of the DOJ
make a written request for additional
information, Defendants shall not
consummate the proposed transaction
or agreement until thirty (30) days after
submitting all such additional
information. Early termination of the
waiting periods in this paragraph may
be requested and, where appropriate,
granted in the same manner as is
applicable under the requirements and
provisions of the HSR Act and rules
promulgated thereunder. This Section
shall be broadly construed and any
ambiguity or uncertainty regarding the
filing of notice under this Section shall
be resolved in favor of filing notice.
XIII. No Reacquisition
AMC may not reacquire any part of
the Divestiture Assets divested under
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
this Final Judgment during the term of
this Final Judgment.
filed a civil antitrust complaint on May
21, 2010, seeking to enjoin the proposed
acquisition and to obtain equitable
XIV. Retention of Jurisdiction
relief. The Complaint alleges that the
This Court retains jurisdiction to
acquisition, if permitted to proceed,
enable any party to this Final Judgment
would combine under common
to apply to this Court at any time for
ownership the two leading, and in some
further orders and directions as may be
cases, only mainstream movie theatres
necessary or appropriate to carry out or
exhibiting first-run, commercial movies
construe this Final Judgment, to modify in parts of the metropolitan areas of
any of its provisions, to enforce
Chicago, Denver, and Indianapolis. The
compliance, and to punish violations of likely effect of this acquisition would be
its provisions.
to lessen competition substantially for
exhibition of first-run, commercial
XV. Expiration of Final Judgment
movies in mainstream theatres in
Unless this Court grants an extension, violation of Section 7 of the Clayton
this Final Judgment shall expire ten (10) Act, 15 U.S.C. 18.
years from the date of its entry.
At the same time the Complaint was
filed, the Plaintiffs also filed a Hold
XVI. Public Interest Determination
Separate Stipulation and Order (‘‘Hold
Entry of this Final Judgment is in the
Separate’’) and a proposed Final
public interest. The parties have
Judgment, which are designed to
complied with the requirements of the
eliminate the anticompetitive effects of
Antitrust Procedures and Penalties Act,
the acquisition. Under the proposed
15 U.S.C. 16, including making copies
Final Judgment, which is explained
available to the public of this Final
more fully below, AMC and Kerasotes
Judgment, the Competitive Impact
are required to divest eight theatres
Statement, and any comments thereon
located in the Chicago, Denver, and
and the United States responses to
Indianapolis areas to acquirer(s)
comments. Based upon the record
acceptable to the Plaintiffs.
before the Court, which includes the
Under the terms of the Hold Separate,
Competitive Impact Statement and any
Defendants will take certain steps to
comments and response to comments
ensure that the eight theatres to be
filed with the Court, entry of this Final
divested are operated as competitively
Judgment is in the public interest.
independent, economically viable and
Date: llllllllllllllllll ongoing business concerns, that they
Court approval subject to procedures of
will remain independent and
Antitrust Procedures and Penalties Act, 15
uninfluenced by the consummation of
U.S.C. 16
the acquisition, and that competition is
lllllllllllllllllllll
maintained during the pendency of the
United States District Judge
ordered divestiture.
UNITED STATES DISTRICT COURT
The Plaintiffs and Defendants have
FOR THE DISTRICT OF COLUMBIA
stipulated that the proposed Final
Judgment may be entered after
UNITED STATES OF AMERICA, STATE
compliance with the APPA. Entry of the
OF ILLINOIS, STATE OF COLORADO, and
proposed Final Judgment would
STATE OF INDIANA, Plaintiffs, v. AMC
terminate this action, except that the
ENTERTAINMENT HOLDINGS, INC., and
KERASOTES SHOWPLACE THEATRES,
Court would retain jurisdiction to
LLC, Defendants.
construe, modify, or enforce the
Civil Action No.: 1:10–cv–00846
provisions of the proposed Final
Judge Kennedy, Henry, H.
Judgment and to punish violations
Filed: 5/21/2010.
thereof.
Competitive Impact Statement
II. Description of the Events Giving Rise
to the Alleged Violation
Plaintiff, United States of America,
pursuant to Section 2(b) of the Antitrust
A. The Defendants and the Proposed
Procedures and Penalties Act (‘‘APPA’’
Transaction
or ‘‘Tunney Act’’), 15 U.S.C.16(b)–(h),
AMC is a Delaware corporation with
files this Competitive Impact Statement
relating to the proposed Final Judgment its headquarters in Kansas City,
submitted for entry in this civil antitrust Missouri. It is the holding company of
AMC Entertainment, Inc. AMC owns or
proceeding.
operates 304 theatres containing 4,574
I. Nature and Purpose of the Proceeding screens in locations throughout the
On January 19, 2010, Defendant AMC United States and four foreign countries.
Measured by number of screens, AMC is
Entertainment Holdings, Inc. (‘‘AMC’’)
the second-largest theatre exhibitor in
agreed to acquire most of the assets of
the United States and had revenues of
Defendant Kerasotes Showplace
approximately $2.26 billion in 2009.
Theatres, LLC (‘‘Kerasotes’’). Plaintiffs
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
31473
Kerasotes is a Delaware corporation
with its principal place of business in
Chicago, Illinois. It owns or operates 96
theatres with 973 screens in various
states. Kerasotes is the sixth-largest
theatre exhibitor in the United States
and earned revenue of approximately
$327.7 million in 2009.
On January 19, 2010, AMC and
Kerasotes signed a purchase and sale
agreement under which AMC will
acquire all the outstanding membership
units of Kerasotes, with the exception of
three theatres which will be retained by
the Kerasotes family, for approximately
$275 million.
The proposed transaction, as initially
agreed to by Defendants on January 19,
2010, would lessen competition
substantially as a result of AMC’s
acquisition of Kerasotes. This
acquisition is the subject of the
Complaint and proposed Final
Judgment filed by the Plaintiffs on May
21, 2010.
B. The Competitive Effects of the
Transaction on the Exhibition of FirstRun, Commercial Movies in Mainstream
Theatres
The Complaint alleges that the
exhibition of first-run, commercial
movies in mainstream theatres in areas
the Complaint defines as North
Suburban Chicago, Upper Southwest
Suburban Chicago, Lower Southwest
Suburban Chicago, Upper Northwest
Denver, Lower Northwest Denver, North
Indianapolis, and South Indianapolis
constitute lines of commerce and
relevant markets for antitrust purposes.
1. The Relevant Product and Geographic
Markets
The exercise of defining a relevant
market helps analyze the competitive
effects of a horizontal transaction.
Market definition identifies an area of
competition and enables the
identification of market participants and
the measurement of market shares and
concentration. This exercise is useful to
the extent it illuminates the
transaction’s likely competitive effects.
The Complaint alleges that the
relevant product market within which
to assess the competitive effects of this
transaction is the exhibition of first-run,
commercial movies in mainstream
theatres. Mainstream theatres are movie
theatres that exhibit a variety of firstrun, commercial movies to attract
moviegoers of all ages and offer basic
concessions, such as popcorn, candy
and soft drinks. According to the
Complaint, the experience of viewing a
film in a theatre is an inherently
different experience from other forms of
entertainment, such as a live show, a
E:\FR\FM\03JNN1.SGM
03JNN1
31474
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
sporting event, or viewing a movie in
the home (e.g., on a DVD player or via
pay-per-view). Reflecting the significant
differences between viewing a movie in
a theatre and other forms of
entertainment, ticket prices for movies
are generally very different from prices
for other forms of entertainment. Live
entertainment is typically significantly
more expensive than a movie ticket,
whereas renting a DVD for home
viewing is usually significantly cheaper
than viewing a movie in a theatre.
The Complaint alleges that
moviegoers generally do not regard
theatres showing ‘‘sub-run’’ movies, art
movies, or foreign language movies as
adequate substitutes for mainstream
theatres showing first-run movies. The
Complaint also alleges that ‘‘premiere’’
theaters do not typically serve as
competitive constraints on mainstream
theaters. Although premiere theatres
show first-run, commercial movies, they
typically have more restrictive
admission policies (e.g., minors must be
accompanied by adults for all movies),
charge higher ticket prices, serve
alcoholic beverages, and often have fullservice restaurants or in-service dining.
The Complaint defines seven relevant
geographic markets in the Chicago,
Denver, and Indianapolis areas in which
to measure the competitive effects of
this transaction. Each geographic market
contains a number of mainstream
theatres—most of which are owned by
the Defendants—at which consumers
can view first-run, commercial movies.
The Complaint identifies the relevant
geographic markets as follows: North
Suburban Chicago, Upper Southwest
Suburban Chicago, Lower Southwest
Suburban Chicago, Upper Northwest
Denver, Lower Northwest Denver, North
Indianapolis, and South Indianapolis.
Chicago, Illinois Area
According to the Complaint, the
North Suburban Chicago area, in and
around the communities of Glenview
and Skokie, encompasses AMC’s
Northbrook Court 14, AMC’s Gardens
13, Kerasotes’ Glen 10, Kerasotes’
Village Crossing 18, and Kerasotes’
Showplace 12 (Niles) theatres. There are
no other mainstream theatres in the
North Suburban Chicago area.
The Upper Southwest Suburban
Chicago area, in and around the city of
Naperville, encompasses AMC’s Cantera
30 and Kerasotes’ Showplace Naperville
16 (Naperville) theatres. There are no
other mainstream theatres in the Upper
Southwest Suburban Chicago area.
The Lower Southwest Suburban
Chicago area, in and around the village
of Bolingbrook, encompasses AMC’s
Woodridge 18 and Kerasotes’
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
Showplace 12 (Bolingbrook) theatres.
There is only one non-party mainstream
theatre in the Lower Southwest
Suburban Chicago area—a 16-screen
theatre operated by Cinemark.
Denver, Colorado Area
The Upper Northwest Denver area, in
and around the cities of Louisville and
Broomfield, encompasses AMC’s
Flatiron Crossing 14 and Kerasotes’
Colony Square 12 theatres. There are no
other mainstream theatres in the Upper
Northwest Denver area.
The Lower Northwest Denver area, in
and around the cities of Westminster
and Arvada, encompasses AMC’s
Westminster Promenade 24 and
Kerasotes’ Olde Town 14 theatres. There
are no other mainstream theatres in the
Lower Northwest Denver area.
Indianapolis, Indiana Area
The North Indianapolis area, in and
around the community of Glendale,
encompasses AMC’s Castleton Square
14 and Kerasotes’ Glendale Town 12
theatres. There is only one other nonparty mainstream theatre in the North
Indianapolis area—a Regal theatre with
14 screens.
The South Indianapolis area, in and
around the city of Greenwood,
encompasses AMC’s Greenwood 14 and
Kerasotes’ Showplace 16 and IMAX.
There are no other mainstream theatres
in the South Indianapolis area.
According to the Complaint, the
relevant markets in which to assess the
competitive effects of this transaction
are the mainstream theatres in the
above-mentioned areas: North Suburban
Chicago, Upper Southwest Suburban
Chicago, Lower Southwest Suburban
Chicago, Upper Northwest Denver,
Lower Northwest Denver, North
Indianapolis, and South Indianapolis
areas. A small but significant postacquisition increase in movie ticket
prices by a hypothetical monopolist of
mainstream theatres in those areas
would not cause a sufficient number of
customers to shift to other alternatives,
including to other forms of
entertainment, to non-mainstream
theatres, or to mainstream theatres
outside the relevant geographic markets
described above to make such a price
increase unprofitable.
2. Competitive Effects in the Relevant
Markets
The Complaint alleges that exhibitors
that operate mainstream movie theatres
compete on multiple dimensions.
Exhibitors compete over the quality of
the viewing experience. They compete
to offer the most sophisticated sound
and viewing systems, best picture
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
clarity, nicest seats with the best views,
and cleanest floors and lobbies for
moviegoers. Such exhibitors also
compete on price, knowing that if they
charge too much (or do not offer
sufficiently discounted tickets for
matinees, seniors, children, etc.),
moviegoers will choose to view movies
at rival theatres.
According to the Complaint, the
proposed transaction is likely to
eliminate these multiple dimensions of
competition between AMC and
Kerasotes. In each of the relevant
markets, AMC and Kerasotes are each
other’s most significant competitor,
given their close proximity to one
another and to moviegoers, and the
similarity in their theatres’ size and
quality of viewing experience. Their
competition spurs each to keep its
prices in check and improve its quality.
For example, Kerasotes expanded its
discounts on matinees at its Bolingbrook
12 theatre, in Lower Southwest
Suburban Chicago, after AMC opened
its Woodridge 18 theatre nearby.
Kerasotes retrofitted its Bolingbrook 12
theatre, in Lower Southwest Suburban
Chicago, in response to AMC’s opening
its Woodridge 18 theatre nearby.
As alleged in the Complaint, each of
the relevant markets would see a
significant increase in market
concentration under a measure called
the Herfindahl-Hirschman Index
(‘‘HHI’’), explained in Appendix A of the
Complaint. In the area with the least
change in concentration—the Lower
Southwest Suburban Chicago area—the
proposed transaction would give the
newly combined entity control of two of
the only three mainstream theatres in
that area. In that market the posttransaction HHI would rise to roughly
5,017, representing an increase of 1,221
points. In other markets, the proposed
acquisition would place all of the
mainstream theatres under AMC’s
control, creating a local monopoly and
yielding a post-transaction HHI of
10,000—the maximum.
In the seven relevant markets today,
were AMC or Kerasotes to increase
ticket prices and the other were not to
follow, the exhibitor that increased
price would likely suffer financially, as
a substantial number of its customers
would patronize the other exhibitor’s
theatre. After the transaction, the newly
combined entity would recapture such
losses, making profitable price increases
that would have been unprofitable
before the transaction. Likewise, the
proposed transaction would eliminate
competition between AMC and
Kerasotes over the quality of the
viewing experience at their theatres in
each of the geographic markets at issue.
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
After the transaction, the newly
combined entity would have a reduced
incentive to maintain, upgrade, and
renovate its theatres in the relevant
markets, and to improve its theatres’
amenities and services, thus reducing
the quality of the viewing experience.
The Complaint alleges that the
presence of the other mainstream
theatres in certain of the relevant
geographic markets would be
insufficient to replace the competition
lost due to the transaction, and thus
render unprofitable post-transaction
increases in ticket prices or decreases in
quality by the newly combined entity.
Finally, the Complaint alleges that the
entry of a mainstream theatre that
would deter or counteract an increase in
movie ticket prices or a decline in
theatre quality is unlikely in all of the
relevant markets. Exhibitors are
reluctant to locate new theatres near
existing theatres unless the population
density and demographics makes new
entry viable or the existing theatres do
not have stadium seating. Those
conditions do not exist in any of the
relevant markets. All of these markets
currently have mainstream theatres with
stadium seating. Given the number of
existing comparable theatres,
population density and demographics in
the relevant markets, demand for
additional mainstream theatres in the
areas at issue is not likely to support
entry of a new theatre.
For all of these reasons, the Plaintiffs
have concluded that the proposed
transaction would lessen competition
substantially in the exhibition of firstrun, commercial movies in mainstream
theatres in the North Suburban Chicago
area, Upper Southwest Suburban
Chicago area, Lower Southwest
Suburban Chicago area, Upper
Northwest Denver area, Lower
Northwest Denver area, North
Indianapolis area, and the South
Indianapolis area, eliminate actual and
potential competition between AMC
and Kerasotes, and likely result in
increased ticket prices and lower quality
theatres in those markets. The proposed
transaction therefore violates Section 7
of the Clayton Act.
III. Explanation of the Proposed Final
Judgment
The divestiture requirement of the
proposed Final Judgment will eliminate
the anticompetitive effects of the
acquisitions in each relevant geographic
market, establishing new, independent,
and economically viable competitors.
The proposed Final Judgment requires
AMC, within sixty (60) calendar days
after the filing of the Complaint, or five
(5) days after the notice of the entry of
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
the Final Judgment by the Court,
whichever is later, to divest, as viable
ongoing businesses, a total of eight
theatres in the seven relevant
geographic markets in the Chicago,
Denver, and Indianapolis areas:
Kerasotes Glen 10 and AMC Gardens 13
(North Suburban Chicago), AMC
Cantera 30 (Upper Southwest Suburban
Chicago), Kerasotes Showplace 12
(Bolingbrook) (Lower Southwest
Suburban Chicago), Kerasotes Colony
Square 12 (Upper Northwest Denver),
Kerasotes Olde Town 14 (Lower
Northwest Denver), Kerasotes
Showplace 12 or AMC Castleton Square
12 (North Indianapolis), and AMC
Greenwood 14 (South Indianapolis).
The assets must be divested in such a
way as to satisfy the Plaintiffs that the
theatres can and will be operated by the
purchaser as viable, ongoing businesses
that can compete effectively in the
relevant markets as mainstream theatres
exhibiting first-run, commercial movies.
AMC must take all reasonable steps
necessary to accomplish the divestiture
quickly and shall cooperate with
prospective purchasers.
Until the divestitures take place, AMC
and Kerasotes must maintain the sales
and marketing of the theatres, and
maintain the theatres in operable
condition at current capacity
configurations. Until the divestitures
take place, AMC and Kerasotes must not
transfer or reassign to other areas within
the company their employees with
primary responsibility for the operation
of the theatres, except for transfer bids
initiated by employees pursuant to
Defendants’ regular, established jobposting policies.
In the event that AMC does not
accomplish the divestitures within the
periods prescribed in the proposed
Final Judgment, the Final Judgment
provides that the Court will appoint a
trustee selected by the United States to
effect the divestitures. If a trustee is
appointed, the proposed Final Judgment
provides that AMC will pay all costs
and expenses of the trustee. The
trustee’s commission will be structured
so as to provide an incentive for the
trustee based on the price obtained and
the speed with which the divestitures
are accomplished. After his or her
appointment becomes effective, the
trustee will file monthly reports with
the Court and the parties, setting forth
his or her efforts to accomplish the
divestiture. At the end of six (6) months,
if the divestitures have not been
accomplished, the trustee and the
plaintiffs will make recommendations to
the Court, which shall enter such orders
as appropriate, in order to carry out the
purpose of the trust, including
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
31475
extending the trust or the term of the
trustee’s appointment.
If AMC is unable to effect the
divestitures required herein due to their
inability to obtain the landlords’
consent, Section VI of the proposed
Final Judgment requires AMC to divest
alternative theatre assets that compete
effectively with the theatres for which
the landlord consent was not obtained.
This provision will insure that any
failure by AMC to obtain landlord
consent does not thwart the relief
obtained in the proposed Final
Judgment.
The proposed Final Judgment also
prohibits AMC from acquiring any other
theatres in counties that correspond to
the relevant geographic markets and
Kerasotes from acquiring any other
theatres in Cook County, Illinois,
without providing at least thirty (30)
days notice to the United States
Department of Justice. Such acquisitions
could raise competitive concerns but
might be too small to be reported under
the Hart-Scott-Rodino (‘‘HSR’’)
premerger notification statute.
The divestiture provisions of the
proposed Final Judgment will eliminate
the anticompetitive effects of AMC’s
acquisition of Kerasotes.
IV. Remedies Available to Potential
Private Litigants
Section 4 of the Clayton Act, 15
U.S.C. 15, provides that any person who
has been injured as a result of conduct
prohibited by the antitrust laws may
bring suit in federal court to recover
three times the damages the person has
suffered, as well as costs and reasonable
attorney’s fees. Entry of the proposed
Final Judgment will neither impair nor
assist the bringing of any private
antitrust damage action. Under the
provisions of Section 5(a) of the Clayton
Act, 15 U.S.C. 16(a), the proposed Final
Judgment has no prima facie effect in
any subsequent private lawsuit that may
be brought against Defendants.
V. Procedures Available for
Modification of the Proposed Final
Judgment
The Plaintiffs and Defendants have
stipulated that the proposed Final
Judgment may be entered by the Court
after compliance with the provisions of
the APPA, provided that the Plaintiffs
have not withdrawn their consent. The
APPA conditions entry upon the Court’s
determination that the proposed Final
Judgment is in the public interest.
The APPA provides a period of at
least sixty (60) days preceding the
effective date of the proposed Final
Judgment within which any person may
submit to the United States written
E:\FR\FM\03JNN1.SGM
03JNN1
31476
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
comments regarding the proposed Final
Judgment. Any person who wishes to
comment should do so within sixty (60)
days of the date of publication of this
Competitive Impact Statement in the
Federal Register, or the last date of
publication in a newspaper of the
summary of this Competitive Impact
Statement, whichever is later. All
comments received during this period
will be considered by the United States
Department of Justice, which remains
free to withdraw its consent to the
proposed Final Judgment at any time
prior to the Court’s entry of judgment.
The comments and the response of the
United States will be filed with the
Court and published in the Federal
Register.
Written comments should be
submitted to: John R. Read, Chief,
Litigation III, Antitrust Division, United
States Department of Justice, 450 5th
Street, NW., Suite 4000, Washington,
DC 20530.
The proposed Final Judgment provides
that the Court retains jurisdiction over
this action, and the parties may apply to
the Court for any order necessary or
appropriate for the modification,
interpretation, or enforcement of the
Final Judgment.
sroberts on DSKD5P82C1PROD with NOTICES
VI. Alternatives to the Proposed Final
Judgment
The Plaintiffs considered, as an
alternative to the proposed Final
Judgment, a full trial on the merits
against Defendants. The Plaintiffs could
have continued the litigation and sought
preliminary and permanent injunctions
against AMC’s acquisition of Kerasotes.
The Plaintiffs are satisfied, however,
that the divestiture of assets described
in the proposed Final Judgment will
preserve competition for the provision
of exhibition of first-run, commercial
movies in the relevant markets
identified by the United States. Thus,
the proposed Final Judgment would
achieve all or substantially all of the
relief the Plaintiffs would have obtained
through litigation, but avoids the time,
expense, and uncertainty of a full trial
on the merits of the Complaint.
VII. Standard of Review Under the
APPA for the Proposed Final Judgment
The Clayton Act, as amended by the
APPA, requires that proposed consent
judgments in antitrust cases brought by
the United States be subject to a sixtyday comment period, after which the
court shall determine whether entry of
the proposed Final Judgment ‘‘is in the
public interest.’’ 15 U.S.C. 16(e)(1). In
making that determination, the court, in
accordance with the statute as amended
in 2004, is required to consider:
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
(A) The competitive impact of such
judgment, including termination of alleged
violations, provisions for enforcement and
modification, duration of relief sought,
anticipated effects of alternative remedies
actually considered, whether its terms are
ambiguous, and any other competitive
considerations bearing upon the adequacy of
such judgment that the court deems
necessary to a determination of whether the
consent judgment is in the public interest;
and
(B) The impact of entry of such judgment
upon competition in the relevant market or
markets, upon the public generally and
individuals alleging specific injury from the
violations set forth in the complaint
including consideration of the public benefit,
if any, to be derived from a determination of
the issues at trial.
15 U.S.C. 16(e)(1)(A) & (B). In
considering these statutory factors, the
court’s inquiry is necessarily a limited
one as the government is entitled to
‘‘broad discretion to settle with the
defendant within the reaches of the
public interest.’’ United States v.
Microsoft Corp., 56 F.3d 1448, 1461 (DC
Cir. 1995); see generally United States v.
SBC Commc’ns, Inc., 489 F. Supp. 2d 1
(D.D.C. 2007) (assessing public interest
standard under the Tunney Act); United
States v. InBev N.V./S.A., 2009–2 Trade
Cas. (CCH) ¶76,736, 2009 U.S. Dist.
LEXIS 84787, No. 08–1965 (JR), at *3,
(D.D.C. Aug. 11, 2009) (noting that the
court’s review of a consent judgment is
limited and only inquires ‘‘into whether
the government’s determination that the
proposed remedies will cure the
antitrust violations alleged in the
complaint was reasonable, and whether
the mechanism to enforce the final
judgment are clear and manageable.’’) 1
As the United States Court of Appeals
for the District of Columbia Circuit has
held, under the APPA a court considers,
among other things, the relationship
between the remedy secured and the
specific allegations set forth in the
government’s complaint, whether the
decree is sufficiently clear, whether
enforcement mechanisms are sufficient,
and whether the decree may positively
harm third parties. See Microsoft, 56
F.3d at 1458–62. With respect to the
adequacy of the relief secured by the
decree, a court may not ‘‘engage in an
unrestricted evaluation of what relief
would best serve the public.’’ United
States v. BNS, Inc., 858 F.2d 456, 462
(9th Cir. 1988) (citing United States v.
1 The 2004 amendments substituted ‘‘shall’’ for
‘‘may’’ in directing relevant factors for court to
consider and amended the list of factors to focus on
competitive considerations and to address
potentially ambiguous judgment terms. Compare 15
U.S.C. 16(e) (2004), with 15 U.S.C. 16(e)(1) (2006);
see also SBC Commc’ns, 489 F. Supp. 2d at 11
(concluding that the 2004 amendments ‘‘effected
minimal changes’’ to Tunney Act review).
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Bechtel Corp., 648 F.2d 660, 666 (9th
Cir. 1981)); see also Microsoft, 56 F.3d
at 1460–62; United States v. . Alcoa,
Inc., 152 F. Supp. 2d 37, 40 (D.DC
2001). InBev, 2009 U.S. Dist. LEXIS
84787, at *3. Courts have held that:
[t]he balancing of competing social and
political interests affected by a proposed
antitrust consent decree must be left, in the
first instance, to the discretion of the
Attorney General. The court’s role in
protecting the public interest is one of
insuring that the government has not
breached its duty to the public in consenting
to the decree. The court is required to
determine not whether a particular decree is
the one that will best serve society, but
whether the settlement is ‘‘within the reaches
of the public interest.’’ More elaborate
requirements might undermine the
effectiveness of antitrust enforcement by
consent decree.
Bechtel, 648 F.2d at 666 (emphasis
added) (citations omitted).2 In
determining whether a proposed
settlement is in the public interest, a
district court ‘‘must accord deference to
the government’s predictions about the
efficacy of its remedies, and may not
require that the remedies perfectly
match the alleged violations.’’ SBC
Commc’ns, 489 F. Supp. 2d at 17; see
also Microsoft, 56 F.3d at 1461 (noting
the need for courts to be ‘‘deferential to
the government’s predictions as to the
effect of the proposed remedies’’);
United States v. Archer-DanielsMidland Co., 272 F. Supp. 2d 1, 6 (D.DC
2003) (noting that the court should grant
due respect to the United States’
prediction as to the effect of proposed
remedies, its perception of the market
structure, and its views of the nature of
the case).
Courts have greater flexibility in
approving proposed consent decrees
than in crafting their own decrees
following a finding of liability in a
litigated matter. ‘‘[A] proposed decree
must be approved even if it falls short
of the remedy the court would impose
on its own, as long as it falls within the
range of acceptability or is ‘within the
reaches of public interest.’ ’’ United
States v. Am. Tel. & Tel. Co., 552 F.
Supp. 131, 151 (D.DC 1982) (citations
omitted) (quoting United States v.
Gillette Co., 406 F. Supp. 713, 716 (D.
Mass. 1975)), aff’d sub nom. Maryland
2 Cf. BNS, 858 F.2d at 464 (holding that the
court’s ‘‘ultimate authority under the [APPA] is
limited to approving or disapproving the consent
decree’’); United States v. Gillette Co., 406 F. Supp.
713, 716 (D. Mass. 1975) (noting that, in this way,
the court is constrained to ‘‘look at the overall
picture not hypercritically, nor with a microscope,
but with an artist’s reducing glass’’). See generally
Microsoft, 56 F.3d at 1461 (discussing whether ‘‘the
remedies [obtained in the decree are] so
inconsonant with the allegations charged as to fall
outside of the ‘reaches of the public interest’’’).
E:\FR\FM\03JNN1.SGM
03JNN1
sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
v. United States, 460 U.S. 1001 (1983);
see also United States v. Alcan
Aluminum Ltd., 605 F. Supp. 619, 622
(W.D. Ky. 1985) (approving the consent
decree even though the court would
have imposed a greater remedy). To
meet this standard, the United States
‘‘need only provide a factual basis for
concluding that the settlements are
reasonably adequate remedies for the
alleged harms.’’ SBC Commc’ns, 489 F.
Supp. 2d at 17.
Moreover, the court’s role under the
APPA is limited to reviewing the
remedy in relationship to the violations
that the United States has alleged in its
Complaint, and does not authorize the
court to ‘‘construct [its] own
hypothetical case and then evaluate the
decree against that case.’’ Microsoft, 56
F.3d at 1459; see also InBev, 2009 U.S.
Dist. LEXIS 84787, at *20 (‘‘the ‘public
interest’ is not to be measured by
comparing the violations alleged in the
complaint against those the court
believes could have, or even should
have, been alleged’’). Because the
‘‘court’s authority to review the decree
depends entirely on the government’s
exercising its prosecutorial discretion by
bringing a case in the first place,’’ it
follows that ‘‘the court is only
authorized to review the decree itself,’’
and not to ‘‘effectively redraft the
complaint’’ to inquire into other matters
that the United States did not pursue.
Microsoft, 56 F.3d at 1459–60. As this
Court recently confirmed in SBC
Communications, courts ‘‘cannot look
beyond the complaint in making the
public interest determination unless the
complaint is drafted so narrowly as to
make a mockery of judicial power.’’ SBC
Commc’ns, 489 F. Supp. 2d at 15.
In its 2004 amendments, Congress
made clear its intent to preserve the
practical benefits of utilizing consent
decrees in antitrust enforcement, adding
the unambiguous instruction that
‘‘[n]othing in this section shall be
construed to require the court to
conduct an evidentiary hearing or to
require the court to permit anyone to
intervene.’’ 15 U.S.C. 16(e)(2). The
language wrote into the statute what
Congress intended when it enacted the
Tunney Act in 1974, as Senator Tunney
explained: ‘‘[t]he court is nowhere
compelled to go to trial or to engage in
extended proceedings which might have
the effect of vitiating the benefits of
prompt and less costly settlement
through the consent decree process.’’
119 Cong. Rec. 24,598 (1973) (statement
of Senator Tunney). Rather, the
procedure for the public interest
determination is left to the discretion of
the court, with the recognition that the
court’s ‘‘scope of review remains sharply
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
proscribed by precedent and the nature
of Tunney Act proceedings.’’ SBC
Commc’ns, 489 F. Supp. 2d at 11.3
VIII. Determinative Documents
There are no determinative materials
or documents within the meaning of the
APPA that were considered by the
United States in formulating the
proposed Final Judgment.
Dated: May 21, 2010.
Respectfully submitted,
/s/ lllllllllllllllllll
Gregg I. Malawer (DC Bar No. 481685),
Nina Hale,
Bennett Matelson (DC Bar No. 454551),
Creighton J. Macy,
U.S. Department of Justice Antitrust Division
450 5th Street, NW., Suite 4000,
Washington, DC 20530, Telephone: (202)
616–5943, Fax: (202) 514–7308, E-mail:
gregg.malawer@usdoj.gov, Attorneys for
Plaintiff the United States
[FR Doc. 2010–13394 Filed 6–2–10; 8:45 am]
BILLING CODE 4410–11–P
NEIGHBORHOOD REINVESTMENT
CORPORATION
Neighborworks America; Regular
Board of Directors Sunshine Act
Meeting
TIME AND DATE:
1 p.m., Tuesday, June 1,
2010.
PLACE: 1325 G Street, NW., Suite 800,
Boardroom Washington, DC 20005.
STATUS: Open.
CONTACT PERSON FOR MORE INFORMATION:
Erica Hall, Assistant Corporate Secretary
(202) 220–2376; ehall@nw.org.
Agenda
I. Call To Order.
II. Approval of the Minutes.
III. Approval of the Minutes.
IV. Summary Report of the Audit Committee.
V. Summary Report of the Finance, Budget
and Program Committee.
VI. Summary of the NHSA Special Board
Committee Meeting.
VII. Summary of the NHSA Special Board of
Directors Meeting.
3 See United States v. Enova Corp., 107 F. Supp.
2d 10, 17 (D. DC 2000) (noting that the ‘‘Tunney Act
expressly allows the court to make its public
interest determination on the basis of the
competitive impact statement and response to
comments alone’’); United States v. Mid-Am.
Dairymen, Inc., 1977–1 Trade Cas. (CCH) & 61,508,
at 71,980 (W.D. Mo. 1977) (‘‘Absent a showing of
corrupt failure of the government to discharge its
duty, the Court, in making its public interest
finding, should * * * carefully consider the
explanations of the government in the competitive
impact statement and its responses to comments in
order to determine whether those explanations are
reasonable under the circumstances.’’); S. Rep. No.
93–298, 93d Cong., 1st Sess., at 6 (1973) (‘‘Where
the public interest can be meaningfully evaluated
simply on the basis of briefs and oral arguments,
that is the approach that should be utilized.’’)
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
31477
VIII. Summary Report of the Corporate
Administration Committee.
IX. Board Appointments.
X. Code of Conduct.
XI. Investment Policy.
XII. Strategic Planning Process Timeline.
XIII. Financial Report.
XIV. Corporate Scorecard.
XV. NHSA Update.
XVI. Chief Executive Officer’s Quarterly
Management Report.
XVII. Adjournment
Erica Hall,
Assistant Corporate Secretary.
[FR Doc. 2010–12974 Filed 6–2–10; 8:45 am]
BILLING CODE 7570–02–M
NEIGHBORHOOD REINVESTMENT
CORPORATION
NHSA Special Board of Directors
Meeting; Sunshine Act
TIME AND DATE: 12:30 p.m., Tuesday,
May 11, 2010.
PLACE: 1325 G Street, NW., Suite 800,
Boardroom, Washington, DC 20005.
STATUS: Open.
CONTACT PERSON FOR MORE INFORMATION:
Erica Hall, Assistant Corporate
Secretary, (202) 220–2376;
ehall@nw.org.
AGENDA:
I. Call to Order.
II. Discussion and Recommendation
For Interim Funding.
III. Adjournment.
Erica Hall,
Assistant Corporate Secretary.
[FR Doc. 2010–12975 Filed 6–2–10; 8:45 am]
BILLING CODE 7570–02–M
NUCLEAR REGULATORY
COMMISSION
[Docket No. 52–011; NRC–2008–0252]
Southern Nuclear Operating Company,
et al; Notice of Consideration of
Issuance of Amendment to Early Site
Permit, Proposed No Significant
Hazards Consideration Determination,
and Opportunity for a Hearing
AGENCY: Nuclear Regulatory
Commission.
ACTION: Notice of license amendment
request, opportunity to comment, and
opportunity to request a hearing.
DATES: Submit comments by July 6,
2010. Requests for a hearing or leave to
intervene must be filed by August 2,
2010.
FOR FURTHER INFORMATION CONTACT:
Chandu Patel, Project Manager, AP1000
E:\FR\FM\03JNN1.SGM
03JNN1
Agencies
[Federal Register Volume 75, Number 106 (Thursday, June 3, 2010)]
[Notices]
[Pages 31465-31477]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13394]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
United States, State of Illinois, State of Colorado, and State of
Indiana v. AMC Entertainment Holdings, Inc. and Kerasotes Showplace
Theatres, LLC Proposed Final Judgment and Competitive Impact Statement
Notice is hereby given pursuant to the Antitrust Procedures and
Penalties Act, 15 U.S.C. Section 16(b)-(h), that a proposed Final
Judgment, Stipulation and Competitive Impact Statement have been filed
with the United States District Court for the District of Columbia in
United States of America, State of Illinois, State of Colorado, and
State of Indiana v. AMC Entertainment Holdings, Inc. and Kerasotes
Showplace Theatres, LLC, Civil Action No. 1:10-cv-00846. On May 21,
2010, the United States and co-plaintiffs filed a Complaint alleging
that the proposed acquisition of most of the assets of Kerasotes
Showplace Theatres, LLC by AMC Entertainment Holdings, Inc. would
violate Section 7 of the Clayton Act, 15 U.S.C. 18 by lessening
competition for theatrical exhibition of first-run films in the
Chicago, Denver and Indianapolis metropolitan areas. The proposed Final
Judgment, filed at the same time as the Complaint, requires AMC
Entertainment Holdings, Inc. to divest first-run, commercial movie
theatres, along with certain tangible and intangible assets, in those
three cities in order to proceed with the proposed $275 million
transaction.
Copies of the Complaint, proposed Final Judgment and Competitive
Impact Statement are available for inspection at the Department of
Justice, Antitrust Division, Antitrust Documents Group, 450 Fifth
Street, NW., Suite 1010, Washington, DC 20530 (telephone 202-514-2481),
on the Department of Justice's Web site at https://www.usdoj.gov/atr,
and at the Office of the Clerk of the United States District Court for
the District of Columbia, Washington, DC. Copies of these materials may
be obtained from the Antitrust Division upon request and payment of the
copying fee set by Department of Justice regulations.
Public comment is invited within 60 days of the date of this
notice. Such comments, and responses thereto, will be published in the
Federal Register and filed with the Court. Comments should be directed
to John R. Read, Chief, Litigation III Section, Antitrust Division,
United States Department of Justice, 450 Fifth Street, NW., Suite 4000,
Washington, DC 20530 (telephone: 202-307-0468).
Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
UNITED STATES OF AMERICA, U.S. Department of Justice, Antitrust
Division, 450 Fifth Street, NW., Suite 4000, Washington, DC 20530,
STATE OF ILLINOIS, Office of the Attorney General, State of
Illinois, 100 West Randolph Street, 13th Floor, Chicago, Illinois
60601, STATE OF COLORADO, Office of the Colorado Attorney General,
1525 Sherman St., Seventh Floor, Denver, Colorado 80203, and STATE
OF INDIANA, Consumer Protection Division, Office of the Indiana
Attorney General, Indiana Government Center South, 302 W.
Washington, 5th Floor, Indianapolis, IN 46204, Plaintiffs, v. AMC
ENTERTAINMENT HOLDINGS, INC., 920 Main Street, Kansas City, Missouri
64105 and KERASOTES SHOWPLACE THEATRES, LLC, 224 North Des Plaines,
Suite 200, Chicago, Illinois 60661, Defendants.
Civil Action No: 1:10-cv-00846
Judge: Kennedy, Henry H.
Filed: 5/21/2010.
Complaint
The United States of America, acting under the direction of the
Attorney General of the United States, and the States of Illinois,
Colorado, and Indiana, acting through their Attorneys General, bring
this civil antitrust action to prevent AMC Entertainment Holdings, Inc.
(``AMC'') from acquiring most of the assets of Kerasotes Showplace
Theatres, LLC (``Kerasotes''). If the acquisition is permitted, it
would combine under common ownership the two leading, and in some cases
only, mainstream movie theatres showing first-run commercial movies in
certain parts of the metropolitan areas of Chicago, Denver, and
Indianapolis. The transaction would substantially lessen competition
and tend to create a monopoly in mainstream theatres in these markets
in violation of Section 7 of the Clayton Act, 15 U.S.C. 18.
I. Jurisdiction and Venue
1. This action is filed by the United States pursuant to Section 15
of the Clayton Act, as amended, 15 U.S.C. 25, to obtain equitable
relief and to prevent a violation of Section 7 of the Clayton Act, as
amended, 15 U.S.C. 18. The States of Illinois, Colorado and Indiana
bring this action under Section 16 of the Clayton Act, 15 U.S.C. 26, to
prevent the defendants from violating Section 7 of the Clayton Act, as
amended, 15 U.S.C. 18.
2. Defendants have consented to personal jurisdiction in this
District. In addition, defendant AMC, through its subsidiary, AMC
Entertainment, Inc., operates theatres in this District. The licensing
and exhibition of first-run, commercial films is a commercial activity
that substantially affects, and is in the flow of, interstate trade and
commerce. Defendants' activities in purchasing equipment, services, and
supplies as well as licensing films for their theatres substantially
affect interstate commerce. The Court has jurisdiction over the subject
matter of this action and jurisdiction over the parties pursuant to 15
U.S.C. 22, 25, and 26, and 28 U.S.C. 1331, 1337(a), and 1345.
3. Venue in this District is proper under 15 U.S.C. 22 and 28
U.S.C. 1391(c).
II. Defendants and the Proposed Transaction
4. Defendant AMC is a Delaware corporation with its headquarters in
Kansas City, Missouri. It is the holding company of AMC Entertainment,
Inc. AMC owns or operates 304 theatres containing 4,574 screens in
locations throughout the United States and four foreign countries.
Measured by number of screens, AMC is the second-largest theatre
circuit in the United States.
5. Defendant Kerasotes is a Delaware corporation with its principal
place of business in Chicago, Illinois. It owns or operates 96 theatres
with 973 screens in various states. Kerasotes is the sixth-largest
theatre circuit in the United States.
6. On January 19, 2010, AMC and Kerasotes signed a purchase and
sale agreement, under which AMC acquired Kerasotes (with the exception
of three theatres that will be retained by the Kerasotes family) for
approximately $275 million.
III. Background of the Movie Industry
7. Theatrical exhibition of feature length motion picture films
(``movies'') provides a major source of out-of-home entertainment in
the United States.
[[Page 31466]]
8. Viewing movies in the theatre is a popular pastime. Over 1.4
billion movie tickets were sold in the United States in 2009, with
total box office revenue exceeding $10.6 billion.
9. Companies that operate movie theatres are called ``exhibitors.''
Some exhibitors own a single theatre, whereas others own a circuit of
theatres within one or more regions of the United States. Established
exhibitors include Regal, Carmike, and Cinemark, as well as AMC and
Kerasotes.
10. Exhibitors set ticket prices for each theatre based on a number
of factors, including the presence and competitive decisions of nearby
comparable theatres.
IV. Relevant Markets
A. Product Market
11. Movies are a unique form of entertainment. The experience of
viewing a movie in a theatre differs from live entertainment (e.g., a
stage production), a sporting event, or viewing a movie in the home
(e.g., on a DVD or via pay-per view).
12. Home viewing of movies is not a reasonable substitute for
viewing movies in a theatre. When consumers watch movies in their
homes, they typically lose several advantages of the theatre
experience, including the size of screen, the sophistication of sound
systems, the opportunity to watch in 3-D, and the social experience of
viewing a movie with other patrons. Additionally, the most popular,
newly released or ``first-run'' movies are not available for home
viewing.
13. Differences in the pricing of various forms of entertainment
also reflect their lack of substitutability in the eyes of consumers.
Ticket prices for movies are generally different from prices for other
forms of entertainment. Tickets for most forms of live entertainment
are typically significantly more expensive than movie tickets. Renting
a DVD for home viewing is usually significantly less expensive than
viewing a movie in a theatre.
14. AMC and Kerasotes operate movie theatres that exhibit first-
run, commercial movies (``mainstream theatres''). Mainstream theatres
typically are multi-plex movie theatres that show a wide variety of
first-run, commercial movies in order to attract all ages of
moviegoers, from children to seniors. Mainstream theatres typically
offer basic concessions, such as popcorn, candy and soft drinks.
15. Mainstream theatres do not compete significantly with ``sub-
run'' theatres specializing in exhibiting movies after the four-to-
five-week first run has ended, with theatres specializing in art movies
or foreign language movies, or with ``premiere'' theatres which
typically offer full-service dining, alcoholic beverages, an adults-
only environment, and other luxury services and amenities not found in
mainstream theatres.
16. Tickets at mainstream theatres usually cost significantly more
than tickets at sub-run theatres. Movies exhibited at sub-run theatres
are no longer new releases, and moviegoers generally do not regard sub-
run movies as adequate substitutes for first-run movies.
17. Theatres that show art movies and foreign language movies are
also not reasonable substitutes for mainstream theatres. Commercial
movies typically appeal to different patrons than other types of
movies, such as art movies or foreign language movies. For example, art
movies tend to appeal more universally to mature audiences. Theatres
that primarily exhibit art movies often contain auditoriums with fewer
seats than mainstream theatres. Typically, art movies are released less
widely than commercial movies.
18. Premiere theaters do not typically serve as a competitive
constraint on mainstream theaters. Premiere theatres often show first-
run, commercial movies, but typically have more restrictive admission
policies (e.g., minors must be accompanied by adults for all movies),
charge higher ticket prices (sometimes as much as double the admission
charged by typical first-run theatres), serve alcoholic beverages, and
often offer full-service restaurants or in-service dining. Premiere
theatres also differ from mainstream theatres in the luxury items and
amenities they offer to their guests. For instance, in addition to
expanded food and beverage offerings, premiere theatres often feature
reserved seating, leather and reclining seats, wait service, and
complimentary refills of popcorn and sodas. Because of these
differences, premiere theatres attract an audience that is distinct
from the audience for mainstream theatres.
19. The relevant product market within which to assess the
competitive effects of this transaction is the exhibition of first-run,
commercial movies in mainstream theatres.
B. Geographic Markets
20. Moviegoers typically are not willing to travel very far from
their homes to attend a movie. As a result, geographic markets for
mainstream theatres are relatively local.
Chicago, Illinois Area
21. AMC and Kerasotes account for a substantial portion of the
mainstream theatre screens and ticket sales in three areas of the
Chicago metropolitan area--the North Suburban Chicago area, the Upper
Southwest Suburban Chicago area, and the Lower Southwest Suburban
Chicago area.
22. The North Suburban Chicago area, in and around the communities
of Glenview and Skokie, encompasses AMC's Northbrook Court 14,
Kerasotes' Glen 10, AMC's Gardens 13, Kerasotes' Village Crossing 18,
and Kerasotes' Showplace 12 (Niles) theatres. There are no other
mainstream theatres in this North Suburban Chicago area.
23. The Upper Southwest Suburban Chicago area, in and around the
city of Naperville, encompasses AMC's Cantera 30 and Kerasotes'
Showplace 16 (Naperville) theatres. There are no other mainstream
theatres in this Upper Southwest Suburban Chicago area.
24. The Lower Southwest Suburban Chicago area, in and around the
village of Bolingbrook, encompasses AMC's Woodridge 18 and Kerasotes'
Showplace 12 (Bolingbrook) theatres. There is only one other non-party
mainstream theatre in this Lower Southwest Suburban area--a 16-screen
Cinemark.
25. Moviegoers who reside in these three suburban Chicago, Illinois
areas are reluctant to travel significant distances out of each of
these areas to attend a movie except in unusual circumstances. The
relevant geographic markets in which to assess the competitive effects
of this transaction are the North Suburban Chicago, Upper Southwest
Suburban Chicago, and Lower Southwest Suburban Chicago areas.
Denver, Colorado Area
26. AMC and Kerasotes account for a substantial portion of the
mainstream theatre screens and ticket sales in two areas of the Denver
metropolitan area.
27. The Upper Northwest Denver area, in and around the cities of
Louisville and Broomfield, encompasses Kerasotes' Colony Square 12 and
AMC's Flatiron Crossing 14 theatres. There are no other mainstream
theatres in this Upper Northwest Denver area.
28. The Lower Northwest Denver area, in and around the cities of
Westminster and Arvada, encompasses AMC's Westminster Promenade 24 and
Kerasotes' Olde Town 14 theatres. There are no other mainstream
theatres in this Lower Northwest Denver area.
29. Moviegoers who reside in these two Denver, Colorado areas are
reluctant
[[Page 31467]]
to travel significant distances out of each of these areas to attend a
movie except in unusual circumstances. The relevant geographic markets
in which to assess the competitive effects of this transaction are the
Upper Northwest Denver and Lower Northwest Denver areas.
Indianapolis, Indiana Area
30. AMC and Kerasotes account for a substantial portion of the
first-run movie screens and ticket sales in two areas of the
Indianapolis metropolitan area.
31. The North Indianapolis area, in and around the community of
Glendale, encompasses AMC's Castleton Square 14 and Kerasotes' Glendale
Town 12 theatres. There is only one other non-party mainstream theatre
in this North Indianapolis area--a Regal theatre with 14 screens.
32. The South Indianapolis area, in and around the city of
Greenwood, encompasses AMC's Greenwood 14 and Kerasotes' Showplace 16
and IMAX. There are no other mainstream theatres in this South
Indianapolis area.
33. Moviegoers who reside in these Indianapolis, Indiana areas are
reluctant to travel significant distances out of each of these areas to
attend a movie except in unusual circumstances. The relevant geographic
market in which to assess the competitive effects of this transaction
are the North Indianapolis and the South Indianapolis areas.
C. The Relevant Markets
34. A small but significant post-acquisition increase in movie
ticket prices at mainstream theatres in the relevant geographic markets
would not cause a sufficient number of customers to shift to other
alternatives, including to other forms of entertainment, to non-
mainstream theatres, or to mainstream theatres outside the relevant
geographic markets described above in sufficient numbers to make such a
price increase unprofitable for the newly combined entity. Therefore,
the relevant markets in which to assess the competitive effects of this
transaction are the mainstream theatres in the North Suburban Chicago,
Upper Southwest Suburban Chicago, Lower Southwest Suburban Chicago,
Upper Northwest Denver, Lower Northwest Denver, North Indianapolis, and
South Indianapolis areas.
V. Competitive Effects
35. Exhibitors compete on multiple dimensions to attract moviegoers
to their theatres over the theatres of their rivals. They compete over
the quality of the viewing experience. They compete to offer the most
sophisticated sound and viewing systems, best picture clarity, nicest
seats with best views, and cleanest floors and lobbies for moviegoers.
Exhibitors also compete on price, knowing that if they charge too much
(or do not offer sufficient discounted tickets for matinees, seniors,
children, etc.), moviegoers might visit rival theatres.
36. In the geographic markets of the North Suburban Chicago area,
the Upper Southwest Suburban Chicago area, the Lower Southwest Suburban
Chicago area, the Upper Northwest Denver area, the Lower Northwest
Denver area, the North Indianapolis area, and the South Indianapolis
area, AMC and Kerasotes compete head-to-head for moviegoers. These
geographic markets are concentrated, and in each market AMC and
Kerasotes are the other's most significant competitor, given their
proximity to one another and similarity in size and quality of viewing
experience. Competition between AMC and Kerasotes spurs each to improve
its quality and keeps prices in check.
Chicago, Illinois Area
37. In the North Suburban Chicago area, the proposed transaction
would give the combined entity control of all five mainstream theatres
in that area, with 83 out of 83 total screens and a 100% share of 2009
box office revenues, which totaled approximately $24.9 million. Using a
measure of market concentration called the Herfindahl-Hirschman Index
(``HHI''), explained in Appendix A, the transaction would yield a post-
transaction HHI of approximately 10,000, representing an increase of
4,856.
38. In the Upper Southwest Suburban Chicago area, the proposed
transaction would give the newly combined entity control of the only
two mainstream theatres in that area, with 46 out of 46 total screens
and a 100% share of 2009 box office revenues, which totaled
approximately $16.4 million. The transaction would yield a post-
transaction HHI of approximately 10,000, representing an increase of
4,875.
39. In the Lower Southwest Suburban Chicago area, the proposed
transaction would give the newly combined entity control of two of the
three mainstream theatres in that area, with 30 out of 46 total screens
and a 53.0% share of 2009 box office revenues, which totaled
approximately $12.3 million. The transaction would yield a post-
transaction HHI of approximately 5,017, representing an increase of
1,221.
Denver, Colorado Area
40. In the Upper Northwest Denver area, the proposed transaction
would give the newly combined entity control of the only two mainstream
theatres in that area, with 26 out of 26 total screens and a 100% share
of 2009 box office revenues, which totaled approximately $5.3 million.
The transaction would yield a post-transaction HHI of approximately
10,000, representing an increase of 4,356.
41. In the Lower Northwest Denver area, the proposed transaction
would give the newly combined entity control of the only two mainstream
theatres in that area, with 38 out of 38 total screens and a 100% share
of 2009 box office revenues, which totaled approximately $13.3 million.
The transaction would yield a post-transaction HHI of approximately
10,000, representing an increase of 3,669.
Indianapolis, Indiana Area
42. In the North Indianapolis area, the proposed transaction would
give the newly combined entity control of two of the three mainstream
theatres in that area, with 26 out of 40 total screens and a 76.1%
share of 2009 box office revenues, which totaled approximately $9.3
million. The transaction would yield a post-transaction HHI of
approximately 6,357, representing an increase of 2,689.
43. In the South Indianapolis area, the proposed transaction would
give the newly combined entity control of the only two mainstream
theatres in that area, with 30 out of 30 total screens and a 100% share
of 2009 box office revenues, which totaled approximately $10.1 million.
The transaction would yield a post-transaction HHI of approximately
10,000, representing an increase of 4,838.
44. The proposed transaction would likely lessen competition
significantly in the relevant markets. Today, if AMC or Kerasotes were
to increase its prices at a theatre in one of the relevant markets, and
the other did not follow, the theatre that increased its prices might
lose business to the other. The proposed transaction would eliminate
this pricing constraint and is therefore likely to lead to higher
prices for moviegoers, which could take the form of a higher adult
evening ticket price or reduced discounting, e.g., for matinees,
children, seniors, and students.
45. The proposed transaction would also eliminate competition
between AMC and Kerasotes over the quality of the viewing experience in
each of the geographic markets at issue. The combined entity would have
reduced
[[Page 31468]]
incentives to maintain, upgrade, and renovate its theatres in the
relevant markets, and to improve those theatres' amenities and
services, thus reducing the quality of the viewing experience for a
moviegoer.
46. The presence in some of the relevant geographic markets of
other non-party mainstream theatres would be insufficient to replace
the competition lost due to the transaction and thus render
unprofitable post-transaction increases in ticket prices or decreases
in quality by the newly combined entity.
VI. Entry
47. Sufficient and timely entry that would deter or counteract the
anticompetitive effects alleged above is unlikely. Exhibitors are
reluctant to locate new mainstream theatres near existing theatres
unless the population density, demographics, or the quality of existing
theatres makes new entry viable. Those conditions do not exist in any
of the relevant geographic markets.
VII. Violation Alleged
48. The plaintiffs hereby reincorporate paragraphs 1 through 47.
49. The effect of the proposed transaction would be to lessen
competition substantially in the relevant geographic markets in
violation of Section 7 of the Clayton Act, 15 U.S.C. 18.
50. The transaction would likely have the following effects, among
others: (a) Prices for first-run, commercial movie tickets in
mainstream theatres would likely increase to levels above those that
would prevail absent the transaction; and (b) the quality of mainstream
theatres and the mainstream theatre viewing experience in the relevant
geographic areas would likely decrease below levels that would prevail
absent the transaction.
VIII. Requested Relief
51. The plaintiffs request: (a) Adjudication that the proposed
transaction would violate Section 7 of the Clayton Act; (b) permanent
injunctive relief to prevent the consummation of the proposed
transaction; (c) an award to each plaintiff of its costs in this
action; and (d) such other relief as is proper.
Dated: May 21, 2010.
For Plaintiff United States of America
/s/--------------------------------------------------------------------
Christine A. Varney,
Assistant Attorney General, Antitrust Division
/s/--------------------------------------------------------------------
Molly S. Boast,
Deputy Assistant Attorney General
/s/--------------------------------------------------------------------
William F. Cavanaugh, Jr.,
Deputy Assistant Attorney General
/s/--------------------------------------------------------------------
Patricia A. Brink,
Deputy Director of Operations
/s/--------------------------------------------------------------------
John R. Read,
Chief
David Kully,
Assistant Chief
Litigation III
/s/--------------------------------------------------------------------
Gregg I. Malawer, (DC Bar No. 481685)
Nina B. Hale
Bennett J. Matelson, (DC Bar No. 454551)
Creighton J. Macy,
U.S. Department of Justice, Antitrust Division, 450 5th Street, NW.,
Suite 4000, Washington, DC 20530, Telephone: (202) 616-5943, Fax:
(202) 514-7308, E-mail: gregg.malawer@usdoj.gov, Attorneys for
Plaintiff the United States
Dated: May 21, 2010.
For Plaintiff State of Illinois:
Lisa Madigan,
Attorney General
/s/--------------------------------------------------------------------
By: Robert Pratt, Chief, Antitrust Bureau, Office of the Attorney
General, State of Illinois, 100 West Randolph Street, 13th Floor,
Chicago, Illinois 60601, Telephone: (312) 814-3722, Fax: (312) 814-
4209, E-mail: RPratt@atg.state.il.us
For Plaintiff State of Colorado:
John Suthers,
Attorney General
/s/--------------------------------------------------------------------
By: Devin Laiho, Assistant Attorney General, Antitrust Enforcement,
Office of the Colorado Attorney General, 1525 Sherman St., Seventh
Floor, Denver, Colorado 80203, Telephone: (303) 866-5079, Fax: (303)
866-5691, E-mail: Devin.Laiho@state.co.us
For Plaintiff State of Indiana:
Greg Zoeller,
Attorney General
/s/--------------------------------------------------------------------
By: Abigail Lawlis Kuzma, Director and Chief Counsel, Consumer
Protection Division, Office of the Indiana Attorney General, Indiana
Government Center South, 302 W. Washington, 5th Floor, Indianapolis,
IN 46204, Telephone: (317) 234-6843, Fax: (317) 232-7979, E-mail:
AKuzuma@atg.in.gov
Appendix A
Definition of HHI and Calculations for Market
``HHI'' means the Herfindahl-Hirschman Index, a commonly
accepted measure of market concentration. It is calculated by
squaring the market share of each firm competing in the market and
then summing the resulting numbers. For example, for a market
consisting of four firms with shares of thirty, thirty, twenty and
twenty percent, the HHI is 2,600 (30\2\ + 30\2\ + 20\2\ + 20\2\ =
2,600). The HHI takes into account the relative size and
distribution of the firms in a market and approaches zero when a
market consists of a large number of firms of relatively equal size.
The HHI increases both as the number of firms in the market
decreases and as the disparity in size between those firms
increases.
Markets in which the HHI is between 1,000 and 1,800 points are
considered to be moderately concentrated, and those in which the HHI
is in excess of 1,800 points are considered to be concentrated.
Transactions that increase the HHI by more than 100 points in
concentrated markets presumptively raise antitrust concerns under
the Merger Guidelines. See Merger Guidelines 1.51.
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
UNITED STATES OF AMERICA, STATE OF ILLINOIS, STATE OF COLORADO
and STATE OF INDIANA, Plaintiffs, v. AMC ENTERTAINMENT HOLDINGS,
INC., and KERASOTES SHOWPLACE THEATRES, LLC, Defendants.
Civil Action No: 10-0846
Judge:
Filed: 5/21/2010.
Final Judgment
Whereas, Plaintiffs, United States of America, State of Illinois,
State of Colorado, and State of Indiana, filed their Complaint on May
21, 2010, the Plaintiffs and Defendants, AMC Entertainment Holdings,
Inc. (``AMC'') and Kerasotes Showplace Theatres, LLC (``Kerasotes''),
by their respective attorneys, have consented to the entry of this
Final Judgment without trial or adjudication of any issue of fact or
law, and without this Final Judgment constituting any evidence against
or admission by any party regarding any issue of fact or law;
And Whereas, Defendants agree to be bound by the provisions of this
Final Judgment pending its approval by the Court;
And Whereas, the essence of this Final Judgment is the prompt and
certain divestiture of certain rights or assets by the Defendants to
assure that competition is not substantially lessened;
And Whereas, Plaintiffs require Defendants to make certain
divestitures for the purpose of remedying the loss of competition
alleged in the Complaint;
And Whereas, Defendants have represented to the Plaintiffs that the
divestitures required below can and will be made and that Defendants
will later raise no claim of hardship or difficulty as grounds for
asking the Court to modify any of the divestiture provisions contained
below;
Now Therefore, before any testimony is taken, without trial or
adjudication of any issue of fact or law, and upon consent of the
parties, it is ordered, adjudged and decreed:
[[Page 31469]]
I. Jurisdiction
This Court has jurisdiction over the subject matter of and each of
the parties to this action. The Complaint states a claim upon which
relief may be granted against Defendants under Section 7 of the Clayton
Act, as amended (15 U.S.C. 18).
II. Definitions
As used in this Final Judgment:
A. ``Acquirer'' or ``Acquirers'' means the entity or entities to
which AMC divests the Divestiture Assets.
B. ``AMC'' means defendant AMC Entertainment Holdings, Inc., a
Delaware corporation with its principal place of business in Kansas
City, Missouri, its successors and assigns, and its subsidiaries,
divisions, groups, affiliates, partnerships and joint ventures, and
their directors, officers, managers, agents, and employees.
C. ``Kerasotes'' means defendant Kerasotes Showplace Theatres, LLC,
a Delaware corporation with its principal place of business in Chicago,
Illinois, its successors and assigns, and its subsidiaries, divisions,
groups, affiliates, partnerships and joint ventures, and their
directors, officers, managers, agents, and employees.
D. ``Landlord Consent'' means any contractual approval or consent
that the landlord or owner of one or more of the Divestiture Assets, or
of the property on which one or more of the Divestiture Assets is
situated, must grant prior to the transfer of one of the Divestiture
Assets to an Acquirer.
E. ``Divestiture Assets'' means the following theatre assets:
------------------------------------------------------------------------
Theatre Address
------------------------------------------------------------------------
1............... AMC Cantera 30............ 28250 Diehl Road,
Warrenville, IL 60555.
2............... Kerasotes Showplace 12 1221 West Boughton Road,
(Bolingbrook). Bolingbrook, IL 60440.
3............... Kerasotes Glen 10......... 1850 Tower Drive,
Glenview, IL 60026.
4............... AMC Gardens 13............ 4999 Old Orchard Shopping
Center, Skokie, IL 60077,
5............... Kerasotes Colony Square 12 1164 West Dillon Road,
Louisville, CO 80027.
6............... Kerasotes Olde Town 14.... 5550 Wadsworth Boulevard,
Arvada, CO 80002.
7............... Kerasotes Showplace 12 6102 N. Rural Street,
(Glendale 10) OR AMC Indianapolis, IN 46220.
Castleton Square 14. 6020 East 82nd Street,
Indianapolis, IN 46250.
8............... AMC Greenwood 14.......... 461 South Greenwood Park
Drive, Greenwood, IN
46142.
------------------------------------------------------------------------
The term ``Divestiture Assets'' includes:
1. All tangible assets that comprise the business of operating
mainstream theatres that exhibit first-run, commercial movies,
including, but not limited to, real property and improvements, research
and development activities, all equipment, fixed assets, and fixtures,
personal property, inventory, office furniture, materials, supplies,
and other tangible property and all assets used in connection with the
Divestiture Assets; all licenses, permits, and authorizations issued by
any governmental organization relating to the Divestiture Assets; all
contracts (including management contracts), teaming arrangements,
agreements, leases, commitments, certifications, and understandings
relating to the Divestiture Assets, including supply agreements; all
customer lists (including loyalty club data at the option of the
Acquirer(s), copies of which may be retained by AMC at its option),
contracts, accounts, and credit records; all repair and performance
records and all other records relating to the Divestiture Assets;
2. All intangible assets used in the development, production,
servicing, and sale of the Divestiture Assets, including, but not
limited to, all patents, licenses and sublicenses, intellectual
property, copyrights, trademarks, trade names, service marks, service
names, technical information, computer software (except Defendants'
proprietary software) and related documentation, know-how, trade
secrets, drawings, blueprints, designs, design protocols,
specifications for materials, specifications for parts and devices,
safety procedures for the handling of materials and substances, all
research data concerning historic and current research and development
relating to Divestiture Assets, quality assurance and control
procedures, design tools and simulation capability, all manuals and
technical information Defendants provide to their own employees,
customers, suppliers, agents, or licensees, and all research data
concerning historic and current research and development efforts
relating to the Divestiture Assets; provided, however, that this term
does not include assets that the Defendants do not own or that AMC is
not legally able to transfer.
III. Applicability
A. This Final Judgment applies to AMC and Kerasotes, as defined
above, and all other persons in active concert or participation with
any of them who receive actual notice of this Final Judgment by
personal service or otherwise.
B. If, prior to complying with Sections IV and V of this Final
Judgment, Defendants sell or otherwise dispose of all or substantially
all of their assets or of lesser business units that include the
Divestiture Assets, they shall require the purchaser to be bound by the
provisions of this Final Judgment. Defendants need not obtain such an
agreement from the acquirers of the assets divested pursuant to this
Final Judgment.
IV. Divestitures
A. AMC is ordered and directed, within sixty (60) calendar days
after the filing of the Complaint in this matter, or five (5) calendar
days after notice of the entry of this Final Judgment by the Court,
whichever is later, to divest the Divestiture Assets in a manner
consistent with this Final Judgment to one or more Acquirer(s)
acceptable to the United States in its sole discretion (after
consultation with the State of Illinois, the State of Colorado, and the
State of Indiana, as appropriate). The United States, in its sole
discretion, may agree to one or more extensions of this time period,
and shall notify the Court in such circumstances. AMC agrees to use its
best efforts to divest the Divestiture Assets as expeditiously as
possible.
B. In accomplishing the divestitures ordered by this Final
Judgment, AMC promptly shall make known, by usual and customary means,
the availability of the Divestiture Assets. AMC shall inform any person
making inquiry regarding a possible purchase of the Divestiture Assets
that they are being divested pursuant to this Final Judgment and
provide that person with a copy of this Final Judgment. AMC shall offer
to furnish to all prospective Acquirers, subject to customary
confidentiality assurances, all
[[Page 31470]]
information and documents relating to the Divestiture Assets
customarily provided in a due diligence process except such information
or documents subject to the attorney-client privilege or work-product
doctrine. AMC shall make available such information to the Plaintiffs
at the same time that such information is made available to any other
person.
C. AMC shall provide the Acquirer(s) and the United States
information relating to the personnel involved in the operation of the
Divestiture Assets to enable the Acquirer(s) to make offers of
employment. Defendants will not interfere with any negotiations by the
Acquirer(s) to employ any Defendant employee whose primary
responsibility is the operation of the Divestiture Assets.
D. AMC shall permit prospective Acquirer(s) of the Divestiture
Assets to have reasonable access to personnel and to make inspections
of the physical facilities of the Divestiture Assets; access to any and
all environmental, zoning, and other permit documents and information;
and access to any and all financial, operational, or other documents
and information customarily provided as part of a due diligence
process.
E. AMC shall warrant to Acquirer(s) of the Divestiture Assets that
each asset will be operational on the date of sale.
F. Defendants shall not take any action that will impede in any way
the permitting, operation, or divestitures of the Divestiture Assets.
At the option of the Acquirer(s), AMC shall enter into an agreement for
products and services, such as computer support services, that are
reasonably necessary for the Acquirer(s) to effectively operate the
Divestiture Assets during a transition period. The terms and conditions
of any contractual arrangements meant to satisfy this provision must be
commercially reasonable for those products and services for which the
agreement is entered and shall remain in effect for no more than three
months, absent approval of the United States, in its sole discretion
(after consultation with the State of Illinois, the State of Colorado,
and the State of Indiana, as appropriate).
G. AMC shall warrant to the Acquirer(s) that there are no material
defects in the environmental, zoning, or other permits pertaining to
the operation of each asset. Following the sale of the Divestiture
Assets, Defendants will not undertake, directly or indirectly, any
challenges to the environmental, zoning, or other permits relating to
the operation of the Divestiture Assets.
H. Unless the United States (after consultation with the State of
Illinois, the State of Colorado, and the State of Indiana, as
appropriate) otherwise consents in writing, the divestitures made
pursuant to Section IV, or by trustee appointed pursuant to Section V
of this Final Judgment, shall include the entire Divestiture Assets,
and shall be accomplished in such a way as to satisfy the United
States, in its sole discretion (after consultation with the State of
Illinois, the State of Colorado, and the State of Indiana, as
appropriate) that the Divestiture Assets can and will be used by the
Acquirer(s) as part of a viable, ongoing business of operating
mainstream theatres that exhibit first-run, commercial movies.
Divestitures of the Divestiture Assets may be made to one or more
Acquirers, provided that in each instance it is demonstrated to the
sole satisfaction of the United States (after consultation with the
State of Illinois, the State of Colorado, and the State of Indiana, as
appropriate) that the Divestiture Assets will remain viable and the
divestitures of such assets will remedy the competitive harm alleged in
the Complaint. The divestitures, whether pursuant to Section IV or
Section V of this Final Judgment.
(1) Shall be made to Acquirers that, in the United States' sole
judgment (after consultation with the State of Illinois, the State of
Colorado, and the State of Indiana, as appropriate) have the intent and
capability (including the necessary managerial, operational, technical,
and financial capability) of competing effectively in the business of
mainstream theatres exhibiting first-run, commercial movies; and
(2) Shall be accomplished so as to satisfy the United States, in
its sole discretion (after consultation with the State of Illinois, the
State of Colorado, and the State of Indiana, as appropriate) that none
of the terms of any agreement between Acquirers and Defendants give the
ability unreasonably to raise the Acquirers' costs, to lower the
Acquirers' efficiency, or otherwise to interfere in the ability of the
Acquirers to compete effectively.
V. Appointment of Trustee
A. If AMC has not divested the Divestiture Assets within the time
period specified in Section IV(A), AMC shall notify the United States
of that fact in writing. Upon application of the United States, the
Court shall appoint a trustee selected by the United States and
approved by the Court to effect the divestitures of the Divestiture
Assets.
B. After the appointment of a trustee becomes effective, only the
trustee shall have the right to sell the Divestiture Assets. The
trustee shall have the power and authority to accomplish the
divestitures to Acquirer(s) acceptable to the United States (after
consultation with the State of Illinois, the State of Colorado, and the
State of Indiana, as appropriate) at such price and on such terms as
are then obtainable upon reasonable effort by the trustee, subject to
the provisions of Sections IV, V, VI, and VII of this Final Judgment,
and shall have such other powers as this Court deems appropriate.
Subject to Section V(D) of this Final Judgment, the trustee may hire at
the cost and expense of AMC any investment bankers, attorneys, or other
agents, who shall be solely accountable to the trustee, reasonably
necessary in the trustee's judgment to assist in the divestiture.
C. Defendants shall not object to a sale by the trustee on any
ground other than the trustee's malfeasance. Any such objections by
Defendants must be conveyed in writing to the United States and the
trustee within ten (10) calendar days after the trustee has provided
the notice required under Section VII.
D. The trustee shall serve at the cost and expense of AMC, on such
terms and conditions as the United States approves, and shall account
for all monies derived from the sale of the assets sold by the trustee
and all costs and expenses so incurred. After approval by the Court of
the trustee's accounting, including fees for its services and those of
any professionals and agents retained by the trustee, all remaining
money shall be paid to AMC and the trust shall then be terminated. The
compensation of the trustee and any professionals and agents retained
by the trustee shall be reasonable in light of the value of the
Divestiture Assets and based on a fee arrangement providing the trustee
with an incentive based on the price and terms of the divestitures and
the speed with which it is accomplished, but timeliness is paramount.
E. Defendants shall use their best efforts to assist the trustee in
accomplishing the required divestitures. The trustee and any
consultants, accountants, attorneys, and other persons retained by the
trustee shall have full and complete access to the personnel, books,
records, and facilities of the business to be divested, and Defendants
shall develop financial and other information relevant to such business
as the trustee may reasonably request, subject to reasonable protection
for trade secret or other confidential research, development, or
commercial information. Defendants shall take no action to interfere
with or to impede the
[[Page 31471]]
trustee's accomplishment of the divestitures.
F. After its appointment, the trustee shall file monthly reports
with the parties and the Court setting forth the trustee's efforts to
accomplish the divestitures ordered under this Final Judgment. To the
extent such reports contain information that the trustee deems
confidential, such reports shall not be filed in the public docket of
the Court. Such reports shall include the name, address, and telephone
number of each person who, during the preceding month, made an offer to
acquire, expressed an interest in acquiring, entered into negotiations
to acquire, or was contacted or made an inquiry about acquiring, any
interest in the Divestiture Assets, and shall describe in detail each
contact with any such person. The trustee shall maintain full records
of all efforts made to divest the Divestiture Assets.
G. If the trustee has not accomplished the divestitures ordered
under this Final Judgment within six (6) months after its appointment,
the trustee shall promptly file with the Court a report setting forth
(1) the trustee's efforts to accomplish the required divestitures, (2)
the reasons, in the trustee's judgment, why the required divestitures
have not been accomplished, and (3) the trustee's recommendations. To
the extent such reports contain information that the trustee deems
confidential, such reports shall not be filed in the public docket of
the Court. The trustee shall at the same time furnish such report to
the United States, which shall have the right to make additional
recommendations consistent with the purpose of the trust. The Court
thereafter shall enter such orders as it shall deem appropriate to
carry out the purpose of the Final Judgment, which may, if necessary,
include extending the trust and the term of the trustee's appointment
by a period requested by the United States.
VI. Landlord Consent
A. If AMC is unable to effect the divestitures required herein due
to the inability to obtain the Landlord Consent for any of the
Divestiture Assets, AMC shall divest alternative theatre assets that
compete effectively with the theatres for which the Landlord Consent
was not obtained. The United States shall, in its sole discretion
(after consultation with the State of Illinois, the State of Colorado,
and the State of Indiana, as appropriate) determine whether such
theatre assets compete effectively with the theatres for which landlord
consent was not obtained.
B. Within five (5) business days following a determination that
Landlord Consent cannot be obtained for the Divestiture Assets, AMC
shall notify the United States and propose an alternative divestiture
pursuant to Section VI(A). The United States shall have then ten (10)
business days in which to determine whether such theatre assets are a
suitable alternative pursuant to Section VI(A). If AMC's selection is
deemed not to be a suitable alternative, the United States shall in its
sole discretion select the theatre assets to be divested (after
consultation with the State of Illinois, the State of Colorado, and the
State of Indiana, as appropriate).
C. If the trustee is responsible for effecting the divestitures, it
shall notify both the United States and AMC within five (5) business
days following a determination that Landlord Consent cannot be obtained
for the Divestiture Assets. AMC shall thereafter have five (5) business
days to propose an alternative divestiture pursuant to Section VI(A).
The United States shall have then ten (10) business days in which to
determine whether such theatre assets are suitable alternative pursuant
to Section VI(A). If AMC's selection is deemed not to be a suitable
competitive alternative, the United States shall in its sole discretion
select the theatre assets to be divested (after consultation with the
State of Illinois, the State of Colorado, and the State of Indiana, as
appropriate).
VII. Notice of Proposed Divestitures
A. Within two (2) business days following execution of a definitive
divestiture agreement, AMC or the trustee, whichever is then
responsible for effecting the divestitures required herein, shall
notify the United States (and, as appropriate, the State of Illinois,
the State of Colorado, and the State of Indiana), of any proposed
divestitures required by Sections IV or V of this Final Judgment. If
the trustee is responsible, it shall similarly notify Defendants. The
notice shall set forth the details of the proposed divestitures and
list the name, address, and telephone number of each person not
previously identified who offered or expressed an interest in or desire
to acquire any ownership interest in the Divestiture Assets, together
with full details of the same.
B. Within fifteen (15) calendar days of receipt by the United
States (the State of Illinois, the State of Colorado, and the State of
Indiana) of such notice, the United States may request from Defendants,
the proposed Acquirer(s), any other third party, or the trustee, if
applicable, additional information concerning the proposed
divestitures, the proposed Acquirer(s), and any other potential
Acquirer(s). Defendants and the trustee shall furnish any additional
information requested within fifteen (15) calendar days of the receipt
of the request, unless the parties shall otherwise agree.
C. Within thirty (30) calendar days after receipt of the notice or
within twenty (20) calendar days after the United States has been
provided the additional information requested from Defendants, the
proposed Acquirer(s), any third party, and the trustee, whichever is
later, the United States shall provide written notice to Defendants and
the trustee, if there is one, stating whether or not it objects to the
proposed divestitures. If the United States provides written notice
that it does not object, the divestitures may be consummated, subject
only to Defendants' limited right to object to the sale under Section
V(C) of this Final Judgment. Absent written notice that the United
States does not object to the proposed Acquirer(s) or upon objection by
the United States, a divestiture proposed under Section IV or Section V
shall not be consummated. Upon objection by Defendants under Section
V(C), a divestiture proposed under Section V shall not be consummated
unless approved by the Court.
VIII. Financing
Defendants shall not finance all or any part of any purchase made
pursuant to Section IV or V of this Final Judgment.
IX. Hold Separate
Until the divestitures required by this Final Judgment have been
accomplished, Defendants shall take all steps necessary to comply with
the Hold Separate Stipulation and Order entered by this Court.
Defendants shall take no action that would jeopardize the divestitures
ordered by this Court.
X. Affidavits
A. Within twenty (20) calendar days of the filing of the Complaint
in this matter, and every thirty (30) calendar days thereafter until
the divestitures have been completed under Sections IV or V, AMC shall
deliver to the United States an affidavit as to the fact and manner of
its compliance with Sections IV or V of this Final Judgment. Each such
affidavit shall include the name, address, and telephone number of each
person who, during the preceding thirty (30) calendar days, made an
offer to acquire, expressed an interest in acquiring, entered into
negotiations to acquire, or was contacted or made an
[[Page 31472]]
inquiry about acquiring, any interest in the Divestiture Assets, and
shall describe in detail each contact with any such person during that
period. Each such affidavit shall also include a description of the
efforts AMC has taken to solicit buyers for the Divestiture Assets, and
to provide required information to prospective purchasers, including
the limitations, if any, on such information. Assuming the information
set forth in the affidavit is true and complete, any objection by the
United States to information provided by AMC, including limitation on
information, shall be made within fourteen (14) calendar days of
receipt of such affidavit.
B. Within twenty (20) calendar days of the filing of the Complaint
in this matter, AMC shall deliver to the United States an affidavit
that describes in reasonable detail all actions Defendants have taken
and all steps Defendants have implemented on an ongoing basis to comply
with Section IX of this Final Judgment. AMC shall deliver to the United
States an affidavit describing any changes to the efforts and actions
outlined in AMC's earlier affidavits filed pursuant to this section
within fifteen (15) calendar days after the change is implemented.
C. Defendants shall keep all records of all efforts made to
preserve and divest the Divestiture Assets until one year after such
divestitures have been completed.
XI. Compliance Inspection
A. For the purposes of determining or securing compliance with this
Final Judgment, or of determining whether the Final Judgment should be
modified or vacated, and subject to any legally recognized privilege,
from time to time duly authorized representatives of the United States
Department of Justice Antitrust Division (``DOJ''), including
consultants and other persons retained by the United States, shall,
upon written request of an authorized representative of the Assistant
Attorney General in charge of the Antitrust Division, and on reasonable
notice to Defendants, be permitted:
(1) Access during Defendants' office hours to inspect and copy, or
at plaintiffs' option, to require Defendants to provide hard copy or
electronic copies of, all books, ledgers, accounts, records, data, and
documents in the possession, custody, or control of Defendants,
relating to any matters contained in this Final Judgment; and
(2) To interview, either informally or on the record, Defendants'
officers, employees, or agents, who may have their individual counsel
present, regarding such matters. The interviews shall be subject to the
reasonable convenience of the interviewee and without restraint or
interference by Defendants.
B. Upon the written request of an authorized representative of the
Assistant Attorney General in charge of the Antitrust Division,
Defendants shall submit written reports or response to written
interrogatories, under oath if requested, relating to any of the
matters contained in this Final Judgment as may be requested.
C. No information or documents obtained by the means provided in
this section shall be divulged by the United States to any person other
than an authorized representative of the executive branch of the United
States, except in the course of legal proceedings to which the United
States is a party (including grand jury proceedings), or for the
purpose of securing compliance with this Final Judgment, or as
otherwise required by law.
D. If at the time information or documents are furnished by
Defendants to the United States, Defendants represent and identify in
writing the material in any such information or documents to which a
claim of protection may be asserted under Rule 26(c)(1)(G) of the
Federal Rules of Civil Procedure, and Defendants mark each pertinent
page of such material, ``Subject to claim of protection under Rule
26(c)(1)(G) of the Federal Rules of Civil Procedure,'' then the
plaintiffs shall give Defendants ten (10) calendar days notice prior to
divulging such material in any legal proceeding (other than a grand
jury proceeding).
XII. Notification
Unless such transaction is otherwise subject to the reporting and
waiting period requirements of the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, 15 U.S.C. 18a (the ``HSR Act''),
AMC, without providing advance notification to the DOJ, shall not
directly or indirectly acquire any assets of or any interest, including
any financial, security, loan, equity or management interest, in the
business of theatres exhibiting first-run, commercial movies in Cook
County, Illinois; Dupage County, Illinois; Adams County, Colorado;
Boulder County, Colorado; Jefferson County, Colorado; Marion County,
Indiana; and Johnson County, Indiana during a ten year period.
Unless such transaction is otherwise subject to the reporting and
waiting period requirements of the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, 15 U.S.C. 18a (the ``HSR Act''),
Kerasotes, without providing advance notification to the DOJ, shall not
directly or indirectly acquire any assets of or any interest, including
any financial, security, loan, or equity interest, in the business of
theatres exhibiting first-run, commercial movies in Cook County,
Illinois during a ten year period. Notwithstanding the preceding
sentence, in no event shall Kerasotes be required to provide advance
notification under this provision of any of the following activities:
(i) engaging in a sale/leaseback, developer-financed or similar
transaction, or developing internally using its own or third-party
financing, in each case with respect to a newly developed theatre; or
(ii) making an acquisition of not more than two percent of the
outstanding voting securities of a publicly-traded company with
theatres exhibiting first-run, commercial movies where such investment
is made ``solely for the purpose of investment'' as that term is
construed under 15 U.S.C. 802.9.
Such notification shall be provided to the DOJ in the same format
as, and per the instructions relating to the Notification and Report
Form set forth in the Appendix to Part 803 of Title 16 of the Code of
Federal Regulations as amended, except that the information requested
in Items 5 through 9 of the instructions must be provided only about
mainstream theatres that exhibit first-run, commercial movies.
Notification shall be provided at least thirty (30) calendar days prior
to acquiring any such interest, and shall include, beyond what may be
required by the applicable instructions, the names of the principal
representatives of the parties to the agreement who negotiated the
agreement, and any management or strategic plans discussing the
proposed transaction. If within the 30-day period after notification,
representatives of the DOJ make a written request for additional
information, Defendants shall not consummate the proposed transaction
or agreement until thirty (30) days after submitting all such
additional information. Early termination of the waiting periods in
this paragraph may be requested and, where appropriate, granted in the
same manner as is applicable under the requirements and provisions of
the HSR Act and rules promulgated thereunder. This Section shall be
broadly construed and any ambiguity or uncertainty regarding the filing
of notice under this Section shall be resolved in favor of filing
notice.
XIII. No Reacquisition
AMC may not reacquire any part of the Divestiture Assets divested
under
[[Page 31473]]
this Final Judgment during the term of this Final Judgment.
XIV. Retention of Jurisdiction
This Court retains jurisdiction to enable any party to this Final
Judgment to apply to this Court at any time for further orders and
directions as may be necessary or appropriate to carry out or construe
this Final Judgment, to modify any of its provisions, to enforce
compliance, and to punish violations of its provisions.
XV. Expiration of Final Judgment
Unless this Court grants an extension, this Final Judgment shall
expire ten (10) years from the date of its entry.
XVI. Public Interest Determination
Entry of this Final Judgment is in the public interest. The parties
have complied with the requirements of the Antitrust Procedures and
Penalties Act, 15 U.S.C. 16, including making copies available to the
public of this Final Judgment, the Competitive Impact Statement, and
any comments thereon and the United States responses to comments. Based
upon the record before the Court, which includes the Competitive Impact
Statement and any comments and response to comments filed with the
Court, entry of this Final Judgment is in the public interest.
Date:------------------------------------------------------------------
Court approval subject to procedures of Antitrust Procedures and
Penalties Act, 15 U.S.C. 16
-----------------------------------------------------------------------
United States District Judge
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
UNITED STATES OF AMERICA, STATE OF ILLINOIS, STATE OF COLORADO,
and STATE OF INDIANA, Plaintiffs, v. AMC ENTERTAINMENT HOLDINGS,
INC., and KERASOTES SHOWPLACE THEATRES, LLC, Defendants.
Civil Action No.: 1:10-cv-00846
Judge Kennedy, Henry, H.
Filed: 5/21/2010.
Competitive Impact Statement
Plaintiff, United States of America, pursuant to Section 2(b) of
the Antitrust Procedures and Penalties Act (``APPA'' or ``Tunney
Act''), 15 U.S.C.16(b)-(h), files this Competitive Impact Statement
relating to the proposed Final Judgment submitted for entry in this
civil antitrust proceeding.
I. Nature and Purpose of the Proceeding
On January 19, 2010, Defendant AMC Entertainment Holdings, Inc.
(``AMC'') agreed to acquire most of the assets of Defendant Kerasotes
Showplace Theatres, LLC (``Kerasotes''). Plaintiffs filed a civil
antitrust complaint on May 21, 2010, seeking to enjoin the proposed
acquisition and to obtain equitable relief. The Complaint alleges that
the acquisition, if permitted to proceed, would combine under common
ownership the two leading, and in some cases, only mainstream movie
theatres exhibiting first-run, commercial movies in parts of the
metropolitan areas of Chicago, Denver, and Indianapolis. The likely
effect of this acquisition would be to lessen competition substantially
for exhibition of first-run, commercial movies in mainstream theatres
in violation of Section 7 of the Clayton Act, 15 U.S.C. 18.
At the same time the Complaint was filed, the Plaintiffs also filed
a Hold Separate Stipulation and Order (``Hold Separate'') and a
proposed Final Judgment, which are designed to eliminate the
anticompetitive effects of the acquisition. Under the proposed Final
Judgment, which is explained more fully below, AMC and Kerasotes are
required to divest eight theatres located in the Chicago, Denver, and
Indianapolis areas to acquirer(s) acceptable to the Plaintiffs.
Under the terms of the Hold Separate, Defendants will take certain
steps to ensure that the eight theatres to be divested are operated as
competitively independent, economically viable and ongoing business
concerns, that they will remain independent and uninfluenced by the
consummation of the acquisition, and that competition is maintained
during the pendency of the ordered divestiture.
The Plaintiffs and Defendants have stipulated that the proposed
Final Judgment may be entered after compliance with the APPA. Entry of
the proposed Final Judgment would terminate this action, except that
the Court would retain jurisdiction to construe, modify, or enforce the
provisions of the proposed Final Judgment and to punish violations
thereof.
II. Description of the Events Giving Rise to the Alleged Violation
A. The Defendants and the Proposed Transaction
AMC is a Delaware corporation with its headquarters in Kansas City,
Missouri. It is the holding company of AMC Entertainment, Inc. AMC owns
or operates 304 theatres containing 4,574 screens in locations
throughout the United States and four foreign countries. Measured by
number of screens, AMC is the second-largest theatre exhibitor in the
United States and had revenues of approximately $2.26 billion in 2009.
Kerasotes is a Delaware corporation with its principal place of
business in Chicago, Illinois. It owns or operates 96 theatres with 973
screens in various states. Kerasotes is the sixth-largest theatre
exhibitor in the United States and earned revenue of approximately
$327.7 million in 2009.
On January 19, 2010, AMC and Kerasotes signed a purchase and sale
agreement under which AMC will acquire all the outstanding membership
units of Kerasotes, with the exception of three theatres which will be
retained by the Kerasotes family, for approximately $275 million.
The proposed transaction, as initially agreed to by Defendants on
January 19, 2010, would lessen competition substantially as a result of
AMC's acquisition of Kerasotes. This acquisition is the subject of the
Complaint and proposed Final Judgment filed by the Plaintiffs on May
21, 2010.
B. The Competitive Effects of the Transaction on the Exhibition of
First-Run, Commercial Movies in Mainstream Theatres
The Complaint alleges that the exhibition of first-run, commercial
movies in mainstream theatres in areas the Complaint defines as North
Suburban Chicago, Upper Southwest Suburban Chicago, Lower Southwest
Suburban Chicago, Upper Northwest Denver, Lower Northwest Denver, North
Indianapolis, and South Indianapolis constitute lines of commerce and
relevant markets for antitrust purposes.
1. The Relevant Product and Geographic Markets
The exercise of defining a relevant market help